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Abstract 
Asthma is the leading non-communicable disease among children. Although several 
environmental determinants have already been associated with the development of asthma, 
more research is needed to understand how to manage the exposure to these determinants 
in order to prevent the disease onset. Moreover, the diagnosis and phenotyping of asthma is 
particularly complex in children due to concomitant virus-induced symptoms, transient 
wheezing and the difficulty in obtaining history of recurrent symptoms or exacerbations, 
which may lead to misdiagnosis and inappropriate treatment. Therefore, this thesis aimed 
to provide further insights on the development and diagnosis of paediatric asthma in order 
to improve its prevention and treatment. 
This thesis is based on four studies: 1) a cross-sectional analysis of schoolchildren 
exposed to different microbial diversities in classrooms; 2) a cross-sectional survey 
between schoolchildren with different degrees of exposure to indoor swimming pool 
environments; 3) a systematic review and meta-analysis of studies using exhaled volatile 
organic compound measurements for asthma diagnosis; and 4) a cross-sectional study to 
distinguish individuals with paediatric asthma trough electronic nose analysis of volatile 
organic compounds in exhaled breath condensate samples. 
Classrooms with increased diversity scores showed a significantly lower prevalence of 
children with allergic sensitization, but presented a tendency for a higher risk of functional 
asthma. The risk of allergic sensitization increased with increasing endotoxin and 
Penicillium spp exposure in classrooms.  
On the other hand, children who swam had significantly lower maximum and average 
pupil constriction velocities when compared to both past swimmers and non-swimmers 
(3.8 and 5.1 vs 3.9 and 5.3 vs 4.0 and 5.4 mm/s, respectively). Moreover, levels of exhaled 
nitric oxide and affinity to the beta-2 agonist were significantly higher in current swimmers 
when compared to non-swimmers (70 and 12 vs 60 and 10, respectively in mL and ppb). 
 The systematic review and meta-analysis showed that: firstly, exhaled volatile 
organic compound profiles have high sensitivity and specificity values for asthma 
diagnosis; secondly, individuals with asthma had 6 times higher chance of being diagnosed 
through analysis of exhaled volatile organic compounds than healthy controls; and thirdly, 
diagnosis odds ratios and AUC values were 49.3 and 0.94, respectively. 
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The diagnostic accuracy measurements for our exhaled volatile organic compound 
analysis methodology showed AUC values of 0.81 for both asthma diagnosis and 
persistent asthma diagnosis. Although specificity values were generally lower, accuracy, 
sensitivity and AUC parameter values obtained from exhaled volatile organic compound 
analysis surpassed those from spirometry with bronchodilation in all cases. 
Altogether, this thesis showed that exposure to microbial agents in classrooms and 
disinfection by-products in swimming pools does influence the development or 
exacerbation of asthma in school-aged children. Moreover, the demonstrated methodology 
for exhaled volatile organic compound analysis may not only corroborate paediatric 
asthma diagnosis, but may also assist physicians in their decision to administer inhaled 
corticosteroids. Through these developments, the present thesis is expected to contribute to 
the improvement of both prevention and treatment of paediatric asthma.      
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Resumo 
A asma é a doença não-transmissível mais comum entre crianças. Embora vários 
determinantes ambientais tenham já sido associados ao desenvolvimento de asma, é 
necessária uma investigação mais aprofundada para compreender como podemos 
manipular a exposição a estes determinantes, de forma a prevenir o aparecimento da 
doença. É também necessário ter em conta a complexidade do diagnóstico e fenotipagem 
da asma em idade pediátrica, muito por causa da semelhança dos sintomas associados a 
doenças concomitantes, igualmente comuns neste grupo etário, como sintomas induzidos 
por vírus ou pela pieira intermitente, e que, quando associados à dificuldade em obter o 
histórico clínico, podem levar a um diagnóstico errado e, consequentemente, a um 
tratamento inapropriado. Tendo isto em conta, procurou-se esclarecer hipóteses sobre o 
desenvolvimento e diagnóstico da asma pediátrica, de forma a melhorar a sua prevenção e 
tratamento. 
Esta tese tem por base quatro estudos: 1) uma análise transversal de crianças em idade 
escolar expostas a diferentes níveis de diversidade microbiológica presentes nas salas de 
aula; 2) um estudo transversal entre crianças com diferentes níveis de exposição ao 
ambiente em piscinas interiores; 3) uma revisão sistemática com meta-análise de estudos 
sobre medição de compostos orgânicos voláteis no ar exalado para diagnóstico de asma; e 
4) um estudo transversal focado em distinguir indivíduos com asma em idade pediátrica, 
utilizando um método baseado num sistema de nariz eletrónico para análise dos compostos 
orgânicos voláteis em amostras de condensado de ar exalado. 
As salas de aula que apresentaram uma maior diversidade fúngica estavam associadas 
a uma menor prevalência de sensibilização alérgica, mas mostraram uma tendência para 
um maior risco de asma com alteração da função pulmonar. O risco de sensibilização 
alérgica aumentou com uma maior exposição a endotoxinas e Penicillium spp nas salas de 
aula. 
Por outro lado, crianças que praticam natação mostraram uma diminuição significativa 
da velocidade média e máxima de constrição da pupila, quando comparadas com anteriores 
praticantes de natação, ou com as que nunca praticaram natação (3.8 e 5.1 vs 3.9 e 5.3 vs 
4.0 e 5.4 mm/s, respetivamente). Para além disso, os níveis de óxido nítrico exalado e a 
afinidade ao agonista beta-2 estavam significativamente elevados nos praticantes de 
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natação, quando comparados com os que nunca praticaram (70 e 12 vs 60 e 10, 
respetivamente em mL e ppb). 
A revisão sistemática com meta-análise demonstrou que: primeiro, os perfis de 
compostos orgânicos voláteis no ar exalado apresentam alta sensitividade e especificidade 
para o diagnóstico de asma; segundo, indivíduos com asma têm 6 vezes mais 
probabilidades de serem diferenciados do que os saudáveis; e terceiro, a rácio de 
diagnóstico assertivo e os valores de AUC são respetivamente 49.3 e 0.94. 
A nossa metodologia de análise dos compostos orgânicos voláteis no ar exalado 
apresentou valores de AUC de 0.81, tanto para o diagnóstico de asma em idade pediátrica, 
como para a diferenciação de asma persistente. Apesar de menos específica, a análise dos 
compostos orgânicos voláteis no ar exalado apresentou valores de precisão, sensitividade e 
AUC superiores aos da espirometria com prova de broncodilatação em todos os casos. 
Em síntese, esta tese comprovou que a exposição a agentes microbiológicos em salas 
de aula e a produtos de desinfeção em piscinas interiores influencia tanto o 
desenvolvimento de asma, como a sua exacerbação, nas crianças em idade escolar. Para 
além disso, a metodologia apresentada para a análise dos compostos orgânicos voláteis no 
ar exalado pode não só corroborar o diagnóstico de asma em idade pediátrica, mas também 
auxiliar os médicos na decisão de administrar terapia por corticoide inalado. Através destes 
desenvolvimentos, a presente tese poderá contribuir para a melhoria da prevenção e 
tratamento da asma em idade pediátrica.  
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1 Introduction 
Asthma is the leading non-communicable disease among children, with prevalence 
reaching up to 10% of the paediatric population in most industrialized countries (Braman, 
2006, Asher and Pearce, 2014). Some epigenetics and environmental determinants behind 
the development of paediatric asthma have already been revealed by the scientific 
community, but further research is needed to completely understand the triggers behind its 
onset (Burbank et al., 2017, Yang et al., 2017).  
Indoor air represents one of the most relevant means of environmental exposure 
during childhood, and indoor air microbiological agents have been shown to influence the 
development of allergic diseases (Karvonen et al., 2014). Apart from home, young children 
spend a large section of their daytime at school, mostly within their classrooms, which 
reflects a long term exposure to indoor air microbiota (Ege et al., 2011, Morawska et al., 
2013). If the human immune system does change according to environmental exposure in 
the first years of life, the classroom microbial environment might contribute to either the 
development and/or exacerbation of asthma or, on the other hand, have a protective effect 
against its onset. However, home and classrooms are not the only environments of 
significant exposure in the paediatric population. 
Notwithstanding the recognized health benefits associated with the practice, 
swimming pool attendance is known to be responsible for airway dysfunction in swimmers 
due to chlorine-based disinfection by-products exposure (Bernard et al., 2007, Bernard et 
al., 2015). These products are ingested, inhaled or absorbed via skin during the swimming 
practice, possibly resulting in airways epithelium damage and eventually airway 
hyperresponsiveness (Jacobs et al., 2007, Belda et al., 2008). This has been emphasized by 
several studies published in the last decade, showing an association between swimming 
pool attendance and a higher risk of asthma in children (Bernard et al., 2009, Voisin et al., 
2010, Andersson et al., 2015), which has lead the scientific community to question the 
beliefs regarding swimming practice benefits in the paediatric population (Uyan et al., 
2009). Alterations of the autonomic nervous function have also been associated with 
swimming pool attendance, although endurance exercises and extensive training volume 
are frequently held responsible for these changes somehow disregarding the possible 
influence of the indoor swimming pool environment on the parasympathetic tonus. It is 
therefore possible that environmental exposure in swimming pools may be causing 
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dysautonomia in swimmers, independently of the training volume, ultimately leading to 
development of asthma, even in children swimmers. 
Aside from environmental determinants, asthma diagnosis is an intricate challenge in 
the paediatric population. The diagnosis and phenotyping of asthma is particularly complex 
in children due to concomitant virus-induced symptoms, transient wheezing and the 
difficulty in obtaining history on recurrent symptoms or exacerbations, which may lead to 
misdiagnosis and inappropriate treatment (Contoli and Papi, 2010, Baena-Cagnani and 
Badellino, 2011, Lodrup Carlsen et al., 2011, Konradsen et al., 2015). Therefore, a more 
sensitive biomarker to diagnose asthma in children, combining versatility, non-
invasiveness and accuracy, is needed. 
In the last decade, exhaled volatile organic compounds (VOCs) have been 
increasingly used as biomarkers for several diseases, including asthma (Dallinga et al., 
2010, Ibrahim et al., 2011, Caldeira et al., 2012, Smolinska et al., 2014). Several research 
groups were able to analyse exhaled VOCs, creating models or profiles capable of 
accurately distinguishing individuals with asthma. These biomarkers showed high 
sensitivity and overall accuracy for detecting asthma inflammation, which could be proven 
useful in a real clinical context. Nevertheless, most of these studies lack stability 
measurements and external validation methods. Moreover, almost all of the studies used 
exhaled breath as the VOC collection matrix, which has some inherent limitations that 
would complicate the implementation of exhaled VOC analysis in clinical settings. Studies 
have shown that it is also possible to measure VOCs in exhaled breath condensate (EBC), 
which would be a more convenient matrix for storage, transport and analysis. There are, 
however, no published studies concerning exhaled VOC analysis measured in EBC 
samples for asthma diagnosis or severity monitoring. 
Therefore, this thesis aimed to provide further insights on the development and 
diagnosis of paediatric asthma. 
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2 Literature review 
2.1 Paediatric asthma 
2.1.1 Definition and epidemiology 
Asthma is a complex chronic respiratory disease characterized by airflow obstruction, 
bronchial inflammation and hyperresponsiveness, multiple phenotypes and endotypes, with 
several aetiologies for its onset and exacerbation of symptoms (Lemanske and Busse, 
2010). These symptoms include recurrent episodes of wheezing, dyspnoea, chest tightness, 
and dry cough, particularly at night or in the early morning, and the overall inflammation 
process involves activation of mast cells, eosinophils, T lymphocytes, neutrophils, and 
epithelial cells, with a tendency for a Th2-mediated inflammation profile in atopic 
individuals. Airflow obstruction in asthma can be totally, partially, or not reversible 
without proper medication, and may be resultant from multiple structural and/or 
physiologic factors associated with the disease that individually or collectively contribute 
to airway narrowing, such as airway smooth muscle spasm, airway mucosal oedema, 
mucus hypersecretion, and airway remodelling and inflammation (Lemanske and Busse, 
2003). For many asthmatic patients, the disease usually develops in early childhood. 
Although wheezing episodes may occur during the first three years of life in approximately 
50% of the paediatric population, some of these children will stop wheezing (transient 
wheezers), while others will go on to develop persistent symptoms that will either dissipate 
prior to adolescence, or continue into adulthood (Stern et al., 2008). Moreover, although 
some phenotypes of asthma require less effort to control, some children may develop a 
more severe, generally more Th1-medited, asthma phenotype, which requires continuous 
or near continuous treatment through a combination of oral and inhaled corticosteroids 
with a short-acting β-agonist to achieve a controlled state (Wenzel and Busse, 2007). 
Asthma is the leading non-communicable disease among children and is prevalent in 
approximately one tenth of the paediatric population in most industrialized countries 
(Braman, 2006). According to the Global Asthma Report (2014) and the Institute for 
Health Metrics and Evaluation, asthma in individuals aged from 5 to 19 years old results in 
a burden of approximately 300 to 600 disability adjusted life years (DALYs), the highest 
after the elderly population. When children with asthma experience exacerbations, they are 
often unable to carry out their usual educational activities and may need urgent medical 
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treatment, leading to high hospital admissions. In extreme cases, children may actually die 
from severe symptoms of asthma (Asher and Pearce, 2014). These complications result in 
high associated health care costs, namely in reliever medication, emergency and 
monitoring instrumentation, ambulatory procedures, hospital care, asthma management 
planning and patient education, not accounting the productivity losses associated with 
absenteeism (Bahadori et al., 2009). In Portugal, the average annual cost of a single child 
with asthma exceeds the 600 euros, which represents a total expense of 123 million euros 
per year, considering an estimated asthma prevalence of 11.5% (van den Akker-van Marle 
et al., 2005, EUROSTAT, 2014). 
There are several known determinants of asthma inception and exacerbation. 
Although genetic factors have been shown to contribute significantly to disease expression 
and severity, asthma is genetically classified as a complex disorder and does not follow 
simple Mendelian inheritance characteristics (Ober and Hoffjan, 2006, Lemanske and 
Busse, 2010). Therefore, non-genetic risk factors must be taken into consideration and 
some of the most important determinants in paediatric asthma are prompted through 
environmental exposures.  
 
2.1.2 Environmental determinants 
Environmental exposure plays an important role in the onset and exacerbation of 
paediatric asthma. Aeroallergens, environmental pollution, tobacco smoke and 
biodiversity, all have been shown to partake as environmental determinants (Lemanske and 
Busse, 2010).  
As shown in a study by Arbes et al. (2007) in the United States, where 56.3% of 
asthma cases were attributable to atopy, exposure to aeroallergens is one of the most 
important factors for onset and, predominantly, exacerbation of the disease. Since the 
formation of antigen-specific IgE antibodies to aeroallergens does not usually occur until 2 
to 3 years of life, aeroallergen-induced asthma is uncommon during early childhood but 
begins to increase in prevalence during subsequent years, peaking in the second decade of 
life (Murray et al., 2001, Lemanske and Busse, 2003). When a sensitized individual is 
exposed to specific inhaled allergens, acute asthma symptoms may occur in combination 
with exacerbated airway inflammation. The mechanisms connecting these allergens to the 
development of asthma are not fully established but the significant evidence associating 
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them with asthma morbidity assures their position as environmental determinants 
(Ahluwalia and Matsui, 2011). 
Early-life exposure to tobacco smoke continues to be a significant determinant in 
asthma. Studies have shown that exposure to tobacco smoke increases the expression of 
arginase I in individuals with asthma, altering arginine pathways in the airways and 
increasing airway remodelling (Bergeron et al., 2007). Added effects from tobacco smoke 
exposure have also been associated with a higher risk of polymorphisms in beta2-
adrenergic receptor gene during the gestational period, increasing the risk for childhood 
wheezing and, eventually, asthma (Wang et al., 2008).  
However, tobacco smoke is not the only air pollutant to be associated with asthma. 
Since children spend most of their time indoors, particular attention should be given to 
indoor air quality to further understand the environmental determinants in paediatric 
asthma. Studies have shown that prolonged exposure to coarse, fine and ultrafine 
particulate matter in indoor environments may promote the development of respiratory 
diseases (MacNee and Donaldson, 2003, Cavaleiro Rufo et al., 2016a). Irritant and toxic 
effects have also been observed for many exogenous VOCs, mostly prevenient from every-
day products such as cleaning detergents (Chin et al., 2014, Cavaleiro Rufo et al., 2016b, 
Paciencia et al., 2016). Nevertheless, Nurmatov et al. reviewed, in 2015, a series of studies 
regarding indoor air VOC exposure as determinants of asthma and concluded that “the 
available evidence implicating domestic VOC exposure in the risk of developing and/or 
exacerbating asthma and allergy is of poor quality and inconsistent”, thus further research 
needs to be commenced to shared more light on this subject. Airborne microbial agents 
have also been suggested as a risk factor for asthma, promoting airway inflammation and 
increasing oxidative stress (Mendell et al., 2011, Madureira et al., 2015). However, these 
results need to be interpreted with caution, since the recent biodiversity hypothesis 
considers a balanced microbial exposure to be a preventive factor in asthma development 
(Haahtela, 2014). Shortly, early contact with multiple microbiological agents appears to 
contribute to a preventive immunomodulation, inducing tolerance to allergens through both 
adaptive and innate immune mechanisms, ultimately reducing the risk for allergic diseases 
and asthma in later childhood (Cavaleiro Rufo et al., 2017b).     
 Nevertheless, either as a promoter or preventer, environmental exposure is an 
important determinant for paediatric asthma and therefore needs to be further studied. 
Unfortunately, most of the published studies only focus on home exposure and, although 
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children do spend most of their time at home, there are other important spaces where 
considerable environmental exposure occurs, such as classrooms, gymnasiums or indoor 
swimming pools. 
 
2.1.3 Diagnostic challenges 
Asthma diagnosis in the paediatric population is usually more complicated since there 
are currently no implemented clinical tools to discriminate true asthma from isolated  
symptoms, such as episodic wheezing (Neerincx et al., 2017). As previously mentioned, 
almost 50% of children present any form of wheezing episodes at 6 years of age that may 
be triggered by several conditions not associated with asthma, including viral respiratory 
tract infections, cystic fibrosis, malformations of the respiratory system, foreign body 
aspiration, and gastroesophageal reflux, among others (Lemanske and Busse, 2003). 
Eventually, diseases with concomitant symptoms can hind or mask asthma diagnosis, and 
may even lead to over-diagnosis in some cases. In addition, the existing clinical 
biomarkers are incapable of properly identifying different phenotypes of asthma, thus 
resulting in unoptimized treatment even when an accurate confirmation of asthma has been 
achieved (Chung, 2016). 
Currently, and according to the Global Initiative for Asthma, clinical approaches for 
asthma diagnosis include the analysis of medical history (occurrence of symptoms, 
allergen sensitization and exercise-induced bronchoconstriction), physical examination 
(wheezing auscultation and inspection for physical signs of airflow limitation), and 
diagnostic tests, such as lung function testing, fractional exhaled nitric oxide (NO) 
measurements, bronchoprovocation (i.e. methacholine or histamine), skin-prick-tests (SPT) 
and sputum or bronchoalveolar lavage (BAL) eosinophils count (Global Initiative for 
Asthma, 2017). However, these methods have multiple downsides, either considering 
accuracy, invasiveness, and/or expensiveness. In addition, some of these tests require 
cooperation from the patient, which could result in poorly reproducible results when 
dealing with younger elements of the paediatric population. Table 1 summarises the 
strengths and limitations of the most frequently used clinical tools for asthma diagnosis. 
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Table 1 – Summary of the currently adopted clinical tests for asthma diagnosis and phenotyping. 
Method Assessed parameters Strengths Limitations 
Spirometry with 
bronchodilation 
challenge 
- Lung function 
- Airway 
obstruction and 
reversibility 
- High specificity and 
reproducibility 
- Highly standardized 
- Low sensitivity 
- Effort-dependent 
- Less reliable in children 
Bronchoprovocation 
challenge tests 
- Airway 
responsiveness 
- High sensitivity - Low specificity 
- Bronchoprovocation 
may cause discomfort 
Impulse oscillometry 
with bronchodilation 
challenge 
- Lung function 
- Airway 
obstruction and 
reversibility 
- Effort-independent  
- Able to identify 
proximal or distal 
airway obstructions 
- Appropriate for 
young children and 
frail elderly 
- Lacks proper 
standardization 
- Interpretation of results 
is not as straightforward 
as spirometry 
Exhaled nitric oxide 
measurements 
- Airway 
eosinophilic 
inflammation 
- Fast and easy to 
perform 
- May assist in 
asthma severity 
monitoring 
- Decent indicator for 
allergic asthma 
- Requires complementary 
diagnostic approaches  
- Levels are usually high 
in atopic individuals 
regardless of having 
asthma or not 
Skin-prick-tests - Allergic 
sensitization 
- High sensitivity 
- Cost-effective 
- Rapid to perform 
- Positive response does 
not necessarily mean 
allergic disease 
 
Sputum eosinophils 
count 
- Eosinophilic 
inflammation 
- Direct marker 
- Decent accuracy 
- Requires laboratory 
analysis 
- Sputum induction causes 
discomfort to patient 
- Less useful for 
neutrophilic asthma 
phenotypes 
 
Spirometry is the standard method for measuring airway obstruction and associated 
reversibility, which are major indicators of asthma pathophysiology. Shortly, 
measurements of forced expiratory volume at the first second (FEV1) and forced vital 
capacity (FVC) are conducted during forced expiratory manoeuvres, using a spirometer. A 
bronchodilation challenge may be conducted between two spirometry measurements, with 
an increase of at least 12% and 200mL in FEV1 from baseline to post-bronchodilator 
assessment being accepted as a positive diagnosis for asthma (Global Initiative for Asthma, 
2017). Although spirometry with bronchodilation challenge provides highly specific and 
reproducible results, it has an unpractically low sensitivity for paediatric asthma diagnosis. 
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In fact, Schneider et al. (2009) performed a study with the spirometry assessment of 219 
patients with obstructive airways diseases, and concluded that asthma could not be 
excluded using only spirometry. These results were later supported by Tse and co-workers 
(2013), who tested this method on 1041 children with mild to moderate asthma, reporting a 
sensitivity of only 35.6%, despite obtaining an area under the ROC (AUC) of 0.73. In 
addition, spirometry is effort-dependent and the prediction values are less reliable in young 
individuals, thus not always being the optimal approach for paediatric asthma diagnosis 
(Global Initiative for Asthma, 2017). 
Bronchoprovocation challenge may be performed to measure airway responsiveness 
in patients with symptoms consistent with asthma but showing normal lung function. 
Measurements of airway responsiveness to direct airway challenges, such as inhaled 
methacholine and histamine, or indirect airway challenges, such as inhaled mannitol or 
exercise challenge, may help in asthma diagnosis and phenotyping (Anderson, 2008, 
Global Initiative for Asthma, 2017). Generally, test results are usually expressed as the 
provocative concentration of the agonist causing a given fall of at least 20% in FEV1. 
However, although bronchoprovocation challenge tests are more sensitive than spirometry 
for asthma diagnosis, they are short on specificity, thus generating a significant amount of 
false positive results (Cockcroft, 2010, Kim et al., 2014). Moreover, provoking 
bronchospasm may cause considerable discomfort in patients, particularly in children. 
Impulse oscillometry (IOS) is another method to evaluate lung function and has also 
been used to measure bronchodilator response and bronchoprovocation testing. It is 
performed during normal tidal breathing and, unlike spirometry, requires no effort from the 
patient, which is an important asset in paediatric asthma diagnosis (Manoharan et al., 
2015). However, studies have shown that, although capable of detecting proximal or distal 
airway obstructions, IOS still lacks proper standardization and thus interpretation of its 
results are not as straightforward to the practitioner as spirometry. Therefore, IOS is 
mainly used in predicting loss of asthma control in the paediatric and elderly populations 
(Bickel et al., 2014). 
Exhaled nitric oxide is a biomarker of eosinophilic inflammation and has been 
suggested as a convenient indicator of airway inflammation in asthma due to its non-
invasiveness, rapid testing, and ease of use (Smith et al., 2004). Hence, exhaled NO is 
frequently used in clinical studies to identify individuals with more severe phenotypes of 
asthma, which are normally associated with a higher hyperresponsiveness (Gemicioglu et 
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al., 2014). Our group has recently suggested and published a spirometry adjusted exhaled 
NO index, which showed a good performance in assessing asthma control in children 
(Martins et al., 2017). Nevertheless, exhaled NO measurement is not an useful tool for 
paediatric asthma diagnosis since levels are generally increased in atopic children 
regardless of whether they have asthma or not, and should therefore be seen as a 
complementary tool for asthma phenotyping (Prasad et al., 2006).  
Due to the strong association between asthma and allergic rhinitis, determining the 
allergic status of the patient is usually helpful to identify the phenotype of the disease. 
Skin-prick-tests with allergens are often used as the primary diagnostic tool in determining 
allergic status, since they are cost-effective, have high sensitivities and can be rapidly 
performed (Bernstein et al., 2008). Allergic sensitization is usually defined by a positive 
SPT to at least one of the tested allergens (wheal > 3mm) coupled to a positive histamine 
response (wheal > 3mm) and no positivity in the negative control (wheal < 3mm). 
However, these tests cannot be used to diagnose asthma on their own, and a positive 
response does not necessarily mean that the patient suffers from allergic disease or from a 
Th2-mediated allergic asthma (Global Initiative for Asthma, 2017).    
Eosinophilic inflammation can be directly measured through sputum eosinophils 
count, providing valuable information regarding the cellular and molecular processes in 
eosinophilic-mediated asthma (Romagnoli et al., 2002, Spahn, 2012). This technique 
presents several limitations, however, as sputum induction provides some discomfort to the 
patient (which is less tolerable in children), requires laboratory analysis, and may not 
generate good diagnostic results for the more neutrophilic-mediated asthma phenotypes 
(Covar et al., 2004). 
Table 2 summarizes the sensitivity and specificity values of currently used 
methodologies to assist in asthma diagnosis. Other invasive techniques, such as 
bronchoscopy and biopsy, are highly accurate for examining airway inflammation, but are 
rarely used due to their associated risks. 
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Table 2 - Sensitivity and specificity for each diagnostic test for asthma. Adapted from Rufo et al. 
(2016b) with authorization from the copyright holder. 
Diagnosis Method Reference Asthma patients 
(n) 
Sensitivity 
(%) 
Specificity 
(%) 
Spirometry (Schneider et al., 2009) 90 16 100 
Fev1 < 80% predicted (Smith et al., 2004) 17 29 100 
Fev1 < 90% predicted (Smith et al., 2004) 17 35 93 
Bronchodilator 
reversibility > 12% 
(Tse et al., 2013) 1041 36 90 
Sputum Eosinophils (Smith et al., 2004) 14 86 88 
Exhaled NO > 20 ppb (Smith et al., 2004) 16 88 79 
Exhaled NO >46 ppb (Schneider et al., 2009) 83 32 93 
GINA questionnaire ≥ 1 
symptoms 
(Lim et al., 2014) 164 98 9 
GINA questionnaire ≥ 5 
symptoms 
(Lim et al., 2014) 164 19 92 
 
2.1.4 Future implications 
Paediatric asthma is a troublesome disease affecting a large number of children, 
generating large annual expenses associated with both hospital care and treatment. 
Cultivating preventive actions and enhancing diagnostic approaches would not only reduce 
the burden of disease and associated costs, but also improve treatment administration 
through more specific medication. However, there is still much to unravel regarding 
mechanisms of paediatric asthma inception, particularly concerning environmental 
exposure in children. Moreover, improved methods for asthma diagnosis are required, as 
the evident limitations of the diagnostic tools currently used in clinical settings poorly 
assist physicians in administrating the correct treatment. 
Concerning environmental exposure, special attention should be given to public 
environments, such as schools or other learning facilities, since children spend a large part 
of their time in these environments, corresponding to significant periods of exposure that 
may determine the onset of paediatric asthma (Morawska et al., 2013). On the other hand, 
prediction of therapy response would benefit from non-invasive and easily accessible 
biomarkers of paediatric asthma, preferably if effortlessly gatherable in children at point of 
care. Therefore, breathomics technologies are starting to appear as appealing tools for 
asthma diagnosis among the scientific and medical communities (Boots et al., 2015).    
Environmental determinants and breathomics in paediatric asthma 
 
 
11 
 
2.2 Breathomics in asthma 
Citing Bos et al. (2016), “among the various omics technologies, those that can be 
measured at point of care are likely to prevail in clinical practice”. This is the reason why 
the practical, rapid and non-invasive metabolomic analysis of exhaled air (breathomics) is 
becoming such an appealing option in modern medicine. 
The perception of different metabolites released through the exhaled breath for disease 
diagnosis is definitely not a new concept among the scientific and medical communities. 
Since Aristotle, doctors have been trained to use their sense of smell to detect odours from 
pathological origins, such as the faecal breath characteristic of liver disease, or the stale 
beer smell exhaled by patients with tuberculosis (Loudon, 1994). In the exhaled breath, the 
main olfactible molecular substrates are VOCs, which have been recurrently associated as 
biomarkers of several lung diseases, including asthma (van der Schee et al., 2015b). 
 
2.2.1 The pathophysiological origin of exhaled volatile organic compounds 
To comprehend the potential of exhaled VOCs as biomarkers of lung diseases, it is 
important to understand their origin and how they relate to the pathology. The human 
volatilome (the VOCs released from normal metabolic processes) is utterly complex, with 
a compendium of 872 compounds identified in the exhaled breath alone, in the healthy 
human (de Lacy Costello et al., 2014). These VOCs usually originate from normal 
microbiome metabolism or during the physiological processes of the liver, kidneys, and 
pancreas. After formation, the VOCs are either further oxidized into smaller components 
due to enhanced activity of enzymes, or directly conducted through the bloodstream, being 
subsequently excreted in the exhaled breath (Miekisch et al., 2004, Buszewski et al., 2007, 
van de Kant et al., 2012). 
However, when a pathological condition is present, different patterns of VOCs may be 
released during the biochemical pathways of the inflammatory process, oxidative stress or 
changes in the human microbiome. In asthma pathophysiology, the chronic airway 
inflammation process and oxidative stress are responsible for the volatilome changes 
detected in the exhaled breath (Jiang et al., 2014). In general, oxidative stress is caused by 
reactive oxygen species (ROS) produced during chemotaxis of inflammatory cells and 
apoptosis resultant from the inflammation process. These ROS may leak from the 
mitochondria into the cytoplasm, subsequently promoting the degradation of 
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polyunsaturated fatty acids constituting lepidic structures, such as the bronchial epithelium 
cells membrane, resulting in the formation of volatile hydrocarbons (Mlakar and Spiteller, 
1994, Rufo et al., 2016). These metabolites may either directly enter the blood stream as 
simple hydrocarbon molecules, such as alkanes, or be further oxidised by cytochrome P450 
oxidase enzymes, leading to the production of alcohols, ketones or aldehydes, that are then 
released through the circulatory system (Filipiak et al., 2016). Finally, these pathologically 
originated compounds are excreted among the normal volatilome in the exhaled breath, 
which will generate different breathomic profiles when compared to a “healthy breath” 
(van de Kant et al., 2012). Figure 1 illustrates the pathological origin of exhaled VOCs in 
individuals with asthma. 
 
 
 
Figure 1 – Schematic representation of the production pathway for VOCs associated with asthma 
pathophysiology. Cytokines produced during airway inflammation in asthma may cause mitochondrial 
dysfunction in airway epithelial cells, promoting the release of reactive oxygen species (ROS). This 
ROS may cause depolarization of the lepidic structures in the cellular membrane, releasing volatile 
hydrocarbons that may directly enter the bloodstream, or be further oxidised cytochrome P450 
oxidase enzymes, before being transported to the lungs and released in the exhaled breath. 
 
Several studies have shown that individuals with asthma may be accurately 
distinguished from those without asthma by analysing their breathprints (exhaled VOC 
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profiles)  (Dallinga et al., 2010, Montuschi et al., 2010, Ibrahim et al., 2011, Smolinska et 
al., 2014).  
Since collecting breath is a simple, inexpensive and non-invasive process, breathomics 
appears to be a particularly promising approach for clinical diagnosis, phenotyping and 
monitoring of asthma. However, similarly to what occurs with other omics technologies, 
those associated with breathomics have their relevant limitations. 
 
2.2.2 Methodological benefits and barriers of exhaled breath testing 
There are currently several available technologies to analyse human exhaled breath. The 
most commonly used and recognized technique to identify and, to a certain extent, quantify 
exhaled VOCs, is the mammalian nose. As previously described, humans may use their 
sense of smell to detect odours characteristic of certain pathologies. However, the 
applications of the human nose are limited since most diseases do not produce olfactible 
amounts of compounds to the human, or are only olfactible when the disease is already at a 
significantly severe state. Other mammalians are known to have improved olfaction 
capacities, allowing them to detect abnormal breathprints associated with pathological 
states. A well-known example is Oscar the cat, who was able to smell the imminent death 
of the patients attending a nursing home in Rhode Island (Dosa, 2007). Nevertheless, the 
mammalian nose is currently a considerably limited method for breath analysis and as 
since the 1970s been replaced in breathomics by more precise and effective technologies, 
such as gas-chromatography-based techniques or the electronic nose (Das et al., 2016). 
Most of these technologies have been tested for exhaled air analysis of asthma diagnosis 
and the respective studies have been systematically reviewed by our team (Rufo et al., 
2016). 
First, however, it is important to discuss sample collection methodologies for 
breathomics in asthma. There are two reported matrices for exhaled VOCs assessment: 
exhaled air in its gaseous form, and EBC. Exhaled air is the most frequently used matrix 
for asthma breathomics since it is rapidly and effortlessly collectible, and appears to 
provide reproducible results (Dallinga et al., 2010). Typically, exhaled breath is collected 
using a sample bag, which usually has a septum where a needle may be inserted during 
analysis. In order to avoid contamination from exogenous VOCs, samples are normally 
collected through Tedlar bags (the capacity varies from 1 to 10 L in published studies). The 
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bags themselves are relatively expensive, but may be reused after cleansing with at least 3 
nitrogen flushes (Caldeira et al., 2011). Although collecting gaseous exhaled breath 
appears to be the simplest method for asthma breathomics, the samples occupy large 
storage volumes and need to be analysed in a maximum of 6 hours after collection 
(Mochalski et al., 2009), which is a considerable barrier in real clinical applications. 
Contrasting with gaseous exhaled breath, EBC collection takes more time to collect since it 
requires subjects to breath normally through a gas condensing device during 10 to 15 
minutes and involves sampling processing and heating before analysis, possibly resulting 
in the loss of some VOCs (Hüttmann et al., 2011). However, samples can be stored and 
frozen in glass tubes until analysis, allowing shipping and examination of multiple samples 
at once, which is an important advantage in the clinical diagnosis of highly prevalent 
diseases, such as paediatric asthma. Moreover, analysing the condensate sample itself does 
not appear to produce as good results as gaseous exhaled breath (Izquierdo-García et al., 
2011, Carraro et al., 2013), although Hüttmann et al. (2011) showed that it is still possible 
to heat the condensate samples in order to release and measure VOCs in gaseous form.   
Concerning assessment technology, gas-chromatography coupled to mass-
spectrometry (GC-MS) has been consistently described as a good method for breathomics, 
and has been the most commonly used methodology for distinguishing breath samples of 
individuals with asthma in studies (Dallinga et al., 2010, Ibrahim et al., 2011, Caldeira et 
al., 2012). This technology not only allows the identification of compounds in a gaseous 
mixture, but also their relative quantification. Several studies showed improved diagnostic 
performances with enhanced versions of the GC-MS system, such as using two sequential 
chromatographers coupled to a time-of-flight mass-spectrometer (GCxGC-ToF-MS), as 
shown by Caldeira et al. (2011), allowing the distinction of children with allergic asthma 
from healthy controls and being able to identify the most discriminative compounds. A 
different approach was presented by Schivo and co-workers (2013), who used GC coupled 
to differential mobility and mass spectrometry (GC-DMS-MS) to successfully distinguish 
patients with asthma from controls. A summary of studies using GC-based technologies for 
asthma diagnosis is presented in table 3.  
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Table 3 – Summary of studies using GC-based techniques for exhaled breath analysis in asthma 
diagnosis. Adapted from Rufo et al. (2016b) with authorization from the copyright holder. 
Reference Objective Participants Breath collection Technique 
(Olopade et al., 
1997) 
Asthma diagnosis; 
Asthma severity 
monitoring 
12 subjects with acute asthma, 
11 subjects with stable asthma 
and 17 healthy controls 
Tedlar bag 
(50 mL sampled) 
GC-FID 
(Paredi et al., 
2000) 
Asthma diagnosis; 
Asthma severity 
monitoring 
26 subjects with asthma and 14 
healthy controls 
Tedlar bag 
(2 mL sampled) 
GC-FID 
(Delfino et al., 
2003) 
Asthma severity 
monitoring 
21 subjects with asthma Evacuated 
stainless steel 
canister 
GC-MS 
(Lärstad et al., 
2007) 
Asthma diagnosis 13 subjects with asthma and 14 
healthy controls 
Tedlar bag 
(3 L sampled) 
GC-FID 
(Dragonieri et 
al., 2007) 
Asthma diagnosis; 
Asthma severity 
monitoring 
10 subjects with severe asthma, 
10 subjects with mild asthma 
and 20 controls 
Tedlar bag 
(1 L sampled) 
GC-MS 
(Dallinga et al., 
2010) 
Asthma diagnosis 63 children with asthma and 57 
healthy controls 
Tedlar bag 
(5 L sampled) 
GC-MS 
(Montuschi et 
al., 2010) 
Asthma diagnosis 27 subjects with asthma and 24 
controls 
Tedlar bag 
(2 L sampled) 
GC-MS 
(Caldeira et al., 
2011) 
Asthma diagnosis 35 children with asthma and 15 
healthy controls 
Tedlar bag 
(1 L sampled) 
GC-MS 
(Ibrahim et al., 
2011) 
Asthma diagnosis 35 subjects with asthma and 23 
healthy controls 
3 L collected 
directly in 
adsorbent pipes 
(Tenax) 
GC-MS 
(Gahleitner et 
al., 2013) 
Asthma diagnosis 11 subjects with asthma and 12 
healthy controls 
2.5 L collected 
directly in 
adsorbent pipes 
(Tenax) 
GC-MS 
(Robroeks et 
al., 2013) 
Asthma severity 
monitoring 
(prospective 
study) 
40 children with asthma Tedlar bag 
(5 L sampled) 
GC-MS 
(Schivo et al., 
2013) 
Asthma diagnosis; 
Differential 
diagnosis 
(Asthma vs. 
COPD) 
13 subjects with asthma, 5 
subjects with COPD and 13 
healthy controls 
Exhaled breath 
condensate 
collector 
(10 to 15 minutes) 
GC-DMS-
MS 
(Smolinska et 
al., 2014) 
Asthma diagnosis 
(Randomized 
trial) 
76 children with asthma, 121 
children with transient wheezing 
and 50 controls 
Tedlar bag 
(1 L sampled) 
GC-MS 
GORD – Gastro-oesophageal reﬂux disease; GC-MS – Gas chromatography coupled with mass spectrometry; GC-FID – Gas 
chromatography coupled with flame ionization detector; GC-DMS-MS – Gas chromatography coupled to a differential mobility 
spectrometer and a mass spectrometer. 
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Although fairly sensible and able to identify a large part of the relevant compounds in 
a breathprint, GC-based techniques usually take a considerable amount of time per sample 
analysis (from 30 minutes to 2 hours per sample), require multiple resources, highly 
trained personnel, generally occupy large spaces and are completely dependent of 
transporter gases, meaning that gas tanks are needed in the proximity of the 
chromatographer (Krilaviciute et al., 2015, Neerincx et al., 2017). These limitations, in 
combination with the fact that no real-time findings can be obtained, impede point of care 
measurements to be conducted, or even the implementation of a properly equipped GC 
laboratory in clinical environments. Additionally, the technology is expensive and 
therefore difficult to execute in real clinical applications. 
Ion mobility spectrometry (IMS) is another reported method for breath analysis. 
Shortly, exhaled VOCs are ionized and transported through drift tubes using a gradient 
created by electromagnetic fields. The ions then reach a detector in different drift times, in 
accordance with their characteristic mobility values (Buryakov et al., 1993). Although the 
rapid time-varying electromagnetic fields do allow identification of compounds in real-
time, IMS is still short on accuracy, reproducibility and accurate cross-validation results 
for asthma diagnosis (Zrodnikov and Davis, 2012).   
Another possible method for breath analysis is nuclear magnetic resonance (NMR). 
Unlike GC-MS and IMS, which may be used to analyse VOCs released from any exhaled 
breath matrix, NMR has only been performed in EBC matrices so far (de Laurentiis et al., 
2008). This analytical technique creates a spectrum through the characterization of the 
most discriminant proton-containing low-molecular-mass compounds, providing a 
metabolic fingerprint of the analysed sample. Carraro and co-workers (2007), in a study 
comprising 25 children with asthma and 11 healthy children, were able to correctly identify 
86% of the asthma cases using NMR. However, Izquierdo-García et al. (2011) 
contradicted these results, showing that NMR techniques do not have the sensitivity 
required to observe the endogenous metabolites presented in an EBC matrix. In addition, 
the complex analysis of the spectrograms, the immense dimensions of the spectrometer, 
prolonged acquisition times and overall cost, renders NMR as the least attractive method to 
implement in clinical breathomics. 
Contrasting with GC and NMR techniques, the electronic nose (eNose) technology 
does not identify specific VOCs. Instead, the integrated cross-reactive nonspecific sensor 
arrays are exposed to VOC mixtures and generate a breathprint through pattern recognition 
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algorithms (Wilson and Baietto, 2011). The system can therefore compare and distinguish 
different smells without identifying the exact compounds in each breathprint (Wilson, 
2015, Neerincx et al., 2017). Although GC-MS continues to be the preferred method for 
breathomics in experimental research due to its VOC identification capacity, the 
promptness, portability, relatively low cost and overall convenience, presents the eNose as 
the most appealing technology for point of care applications. Therefore, and since it 
appears to be the suitable method to rapidly analyse the exhaled breath of a large 
population of individuals with paediatric asthma attending clinical settings, the eNose 
technology will be further discussed in the next section. 
 
2.2.3 Exhaled breath analysis by electronic nose 
The eNose technology offers modern, non-invasive and cost-effective approaches to 
improve clinical diagnosis through exhaled breath analysis. Nevertheless, eNose in 
breathomics is a recent reality and still needs to overcome some challenges to finally being 
introduced in a real clinical scenario. Some of these challenges include the incapacity to 
identify individual compounds in complex VOC mixtures, relatively short sensor lifetime, 
slightly lower sensitivity than GC-MS and occasional problems of sensor translation 
(Wilson and Baietto, 2009). On the other hand, eNose instruments have many advantages 
over traditional analytical tools for breathomics, some already mentioned in the previous 
section, including being less expensive, relatively easy to use, rapid sampling and sensor 
recovery times, good precision, low operating costs and higher portability (Wilson, 2015). 
There are many types of eNose instruments with different inherent sensing methods, 
ranging from surface acoustic wave sensors (Gan et al., 2005), quartz crystal microbalance 
arrays (Ali et al., 2003), metal oxide polymers (Green et al., 2011), to nanocomposite 
sensor arrays (Lorwongtragool et al., 2012). One of the most used instruments in 
biomedical applications is the commercially available Cyranose® 320 (Sensigent, 
California, USA) which relies on a nanocomposite sensor array comprising 32 vapour-
sensitive sensors for creating breathprints from the measured VOC mixtures. The method 
of operation consists in setting baseline resistance values for the sensors by sampling 
ambient air, and then drawing the selected sample which will create different resistance 
values according to the VOCs in the mixture. Sensor deflection value in Cyranose® 320 is 
calculated according to the formula presented in equation 1.  
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Equation 1 – Calculation of sensor deflection value according to Cyranose® 320 method of operation. 
 
 
 
 
 
There are already some published studies showing the potential of Cyranose® 320 in 
asthma diagnosis (Table 4). Dragonieri et al. (2007) showed that, in a clinical study 
comprising 20 individuals with asthma and 20 healthy controls, the breathprints of patients 
with asthma were fully separable from healthy controls, suggesting an important eNose 
diagnosis potential. This has been corroborated in a study conducted in the Netherlands, by 
Fens and co-workers (2009), where the authors aimed to correctly distinguish breathprints 
in a population comprised by 30 subjects with chronic obstructive pulmonary disease 
(COPD), 20 subjects with asthma and 40 healthy controls, by analysing their exhaled 
breath through Cyranose® 320. The results showed that breathprints of individuals with 
asthma were significantly different from those with COPD or with no respiratory diseases 
(controls) with an accuracy of respectively 96 and 95%. The external validation of the 
mentioned results was demonstrated in a later study by Fens et al. (2011), where they 
showed that the accuracy for discriminating asthma from COPD was not confounded by 
“current smoking” status. 
Another interesting aspect of the eNose technology is its capacity to differentially 
diagnose individuals with added conditions suffering from the same disease (Rufo et al., 
2016). For instance, Timms and co-workers (2012) performed a study aiming to 
distinguish patients suffering from asthma with and without concomitant gastro-
oesophageal reﬂux disease, using the Cyranose® 320 system. The population included 20 
individuals with asthma and the results showed that breathprints from individuals with 
gastro-oesophageal reﬂux disease were highly distinguishable from those without reflux, in 
the asthma population. Moreover, eNose may prove to be an important tool to assist in 
asthma treatment administration, since van der Schee et al. (2013) found that exhaled VOC 
profiles were able to predict steroid responsiveness in patients with asthma with greater 
accuracy than exhaled NO and sputum eosinophils count, in a cross-sectional study 
comprising 25 subjects with asthma and 20 controls. 
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Table 4 - Summary of studies using eNose-based techniques for exhaled breath analysis in asthma 
diagnosis. Adapted from Rufo et al. (2016b) with authorization from the copyright holder. 
Reference Objective Participants Breath collection Instrument 
(Dragonieri et 
al., 2007) 
Asthma diagnosis; 
Asthma severity 
monitoring 
10 subjects with severe 
asthma, 10 subjects with 
mild asthma and 20 
controls 
Tedlar bag 
(1 L sampled) 
Cyranose® 320 
(Fens et al., 
2009) 
Differential diagnosis 
(Asthma vs. COPD) 
30 subjects with COPD, 
20 subjects with asthma 
and 40 controls 
Tedlar bag 
(10 L sampled) 
Cyranose® 320 
(Fens et al., 
2011) 
Differential diagnosis 
(Asthma vs. COPD) 
40 subjects with COPD 
and 60 subjects with 
asthma 
Tedlar bag 
(10 L sampled) 
Cyranose® 320 
(Timms et al., 
2012) 
Differential diagnosis 
(Asthma with GORD vs. 
Asthma without GORD) 
17 subjects with COPD, 
20 subjects with asthma 
and 7 healthy controls 
Tedlar bag 
(no volume 
specified) 
Cyranose® 320 
(van der 
Schee et al., 
2013) 
Asthma diagnosis; 
Steroid responsiveness 
prediction 
25 subjects with asthma 
and 20 controls 
Inert bag 
(not specified) 
Cyranose® 320 
 
Unfortunately, there are still no published studies showing the potential of eNose 
technology in the ever so challenging paediatric asthma diagnosis. The closest research on 
this matter has been performed by van der Schee et al. (2015), where the exhaled breath 
profile of 97 asymptomatic children was successfully discriminated from those of 81 
wheezing children with an AUC of 0.77. Moreover, although presenting high sensitivity 
values for asthma diagnosis in adults, most of these studies lack stability measurements 
and external validation methods, fail to blind the diagnostic standard before performing 
breath analysis, and almost all of the studies use gaseous exhaled breath as the VOC 
collection matrix. As previously mentioned, exhaled air samples occupy large volumes (at 
least 1L per sample has been reported) and must be analysed in 6 hours after collection to 
avoid contamination of the sample bags (Mochalski et al., 2009). In addition, sample bags 
are expensive and, although reusable, they must be cleansed with multiple nitrogen flushes 
before each collection, thus being dependent of unpractical gas tanks (Caldeira et al., 
2011). All these limitations would hamper the successful implementation of the eNose 
technology in real clinical diagnostics. Therefore, there is an emphasised need to 
investigate the accuracy of eNose in paediatric asthma diagnosis and, at the same time, 
develop a more practical method to allow large scale exhaled breath analysis in real 
clinical settings. 
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3 Aims of the thesis 
The overall objective of the present thesis was to provide further insights on the 
development and diagnosis of paediatric asthma. 
More specifically, the thesis programme aimed to: 
 
1. Assess determinants of paediatric asthma in children-occupied environments, such as 
schools (study I) and indoor swimming pools (study II). 
 
2. Evaluate the accuracy of exhaled VOC analysis in asthma diagnosis (study III). 
 
3. Develop, validate and evaluate a breathomics model based on eNose exhaled breath 
condensate analysis for paediatric asthma diagnosis (study IV). 
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4 Materials and methods 
This thesis is based on three different study designs: 
1. A cross-sectional survey to observe how the prevalence of allergic sensitization and 
asthma in schoolchildren is influenced by the exposure to indoor air bacteria and 
fungi in classrooms, and by parasympathetic dysautonomia resultant from 
swimming pool exposure (studies I and II). 
2. A systematic review and meta-analysis of published methodologies regarding 
exhaled VOC analysis for diagnosis and phenotyping of asthma (study III). 
3. A cross-sectional study to evaluate the accuracy of a practical non-invasive eNose-
based VOC analysis methodology for paediatric asthma diagnosis, using EBC 
matrices (study IV) 
 
4.1 Study design and participants 
4.1.1 Determinants of respiratory and allergic diseases in children-occupied 
environments (studies I and II) 
A total of 20 public primary schools located in the city of Porto, Portugal, were 
invited to participate in this cross-sectional survey, corresponding to a total of 71 
classrooms. The study was authorized by the Ethics Committee for Health of S. João 
Hospital Centre and by the schools’ Directive Councils. Parents and legal guardians of 
1602 children attending the participating schools were contacted and sent written 
information concerning the project. A written consent was retrieved for 916 children 
(57.2% participation rate), but only 858 completed the clinical assessment as the remaining 
58 children refused to perform the clinical tests despite the legal guardians’ consent 
(Figure 2). Therefore, and considering a confidence level of 95%, the estimated confidence 
interval for the sample size was 2.42. For convenience, the aforementioned sample of 
individuals shall be referred as “school population” throughout the thesis. 
Indoor air sampling and health assessment campaigns occurred during the heating 
season in two different periods: from January to April 2014, and from October 2014 to 
March 2015 (10 schools per period). The heating season was chosen since the air exchange 
rates in schools are usually lower during this period. Throughout the sampling, indoor air 
bacteria, fungi and lipopolysaccharides (LPS) were collected. 
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Concurrently with the indoor sampling, the clinical assessment of the participating 
children was performed in the respective school. Height, weight, lung function (spirometry 
with bronchodilation) and exhaled NO levels were measured in participating children. 
Skin-prick-tests and pupillometry were also performed on the participants by a trained 
professional. A standardized ISAAC-based self-reported questionnaire focused on their 
child’s respiratory and allergic symptoms, as well as on swimming practice, was filled by 
the parents. 
Eligible children
n=1602 children
School 1
n=36
School 2
n=79
School 3
n=92
School 4
n=89
School 5
n=79
School 6
n=79
School 7
n=65
School 8
n=51
School 9
n=70
School 10
n=91
Included: n=20
Excluded: n=16
Included: n=56
Excluded: n=23
Included: n=66
Excluded: n=26
Included: n=55
Excluded: n=34
Included: n=67
Excluded: n=12
Included: n=51
Excluded: n=28
Included: n=48
Excluded: n=17
Included: n=32
Excluded: n=19
Included: n=53
Excluded: n=17
Included: n=58
Excluded: n=33
School 11
n=79
School 12
n=80
School 13
n=62
School 14
n=88
School 15
n=104
School 16
n=130
School 17
n=48
School 18
n=85
School 19
n=104
School 20
n=91
Included: n=44
Excluded: n=35
Included: n=39
Excluded: n=41
Included: n=34
Excluded: n=28
Included: n=30
Excluded: n=58
Included: n=47
Excluded: n=57
Included: n=65
Excluded: n=65
Included: n=22
Excluded: n=26
Included: n=31
Excluded: n=54
Included: n=52
Excluded: n=52
Included: n=46
Excluded: n=45
Excluded: n=686
(did not return consent)
Enrolled: n=916
(858 + 58 who refused to perform clinical tests)
 
Figure 2 – Recruitment flow in the 20 participating schools (studies I and II). Reprinted from 
Cavaleiro Rufo et al. (2016) with authorization of the copyright holder. 
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4.1.2 Search strategy, inclusion criteria and data extraction (study III) 
A PRISMA oriented systematic search (Moher et al., 2009) was performed until 31 
October 2014 in PubMed, Scopus, Compendex, Inspec, ScienceDirect, Academic Search 
Complete, Web of Science and the Cochrane library. The search was conducted through 
the combination of the keywords “asthma”, “exhaled”, and “VOCs” or “volatile organic 
compounds”. Published peer-reviewed full-text articles in English concerning clinical 
studies of asthma diagnosis through exhaled VOCs analysis were assessed for eligibility. 
The inclusion criteria for qualitative synthesis were (a) asthma defined by a trained 
physician or according to official guidelines, such as those validated by the Global 
Initiative for Asthma or the American Thoracic Society/European Respiratory Society; 
(b)VOCs measured in exhaled breath; and (c) clinical studies. 
The exclusion criteria consisted in (a) less than two defined groups for comparing 
VOC levels or profiles; (b) studies focused on diagnosing symptoms of asthma, rather than 
the disease itself. Moreover, presenting the sensitivity and specificity values for asthma 
diagnosis was an additional inclusion criterion for the meta-analysis. Two reviewers 
independently applied the inclusion criteria and any differences were resolved by 
consensus.  
Information regarding study design, settings, population, methodologies (including 
sample collection, analysis techniques, specific compounds and environmental air VOCs 
assessment) and outcomes was gathered. The tests’ sensitivity and specificity data were 
retrieved whenever possible for meta-analysis. 
The quality assessment of the selected studies was conducted according to the Quality 
Assessment of Diagnostic Accuracy Studies (QUADAS) tool (Whiting et al., 2003). To 
better represent the quality assessment, QUADAS quality scores were defined: items 
classified as “Yes” added 1 point to the score; items classified as “No” and as “Unclear” 
added 0 points to the score (Attachment 1). 
 
4.1.3 Recruitment design for the breathomics survey (study IV) 
The cross-sectional study for accuracy testing followed the updated STARD 
guidelines for reporting diagnostic accuracy in studies (Bossuyt et al., 2015). Sample size 
estimation was based on previously reported accuracy measurements obtained through 
meta-analysis of 6 studies focused on exhaled VOCs in asthma diagnosis (Rufo et al., 
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2016), and calculations were performed according to the classic likelihood ratio sample 
size estimation method for diagnostic test studies (Simel et al., 1991). Therefore, 
estimating a sensitivity of 87% and a specificity of 86% for asthma diagnosis for exhaled 
VOC analysis, and considering a sample comparison ratio of 1.0 for balanced judgment 
(disease vs non-disease), power calculations showed that 42 individuals with asthma and 
42 individuals without asthma would be needed to show that the index test at least 
surpasses the 2.90 positive likelihood ratio achieved by spirometry with bronchodilation in 
asthma diagnosis, according to published data (Schneider et al., 2009), with a 95% 
confidence interval. 
Participants, aged 6 to 18 years, were recruited from two distinct settings: during 
regular appointments to a tertiary care outpatient allergy clinic in S. João Hospital Centre, 
Porto, Portugal, from May to September 2016; and during a regular training session of a 
local juvenile football team in Porto, Portugal, between 5 and 13 September 2017. Eligible 
participants were recruited on a random basis, independently of the week day, time period 
of the visit, and appointed physician. After obtaining the legal guardians’ informed consent 
and participant’s agreement, airway reversibility measurements and SPT were performed, 
followed by EBC collection. Medical diagnosis of asthma and associated severity level 
(based on the administered treatment), as well as medical diagnosis of allergic rhinitis and 
atopic dermatitis, was established by an allergy specialist, randomly selected for each 
participant.  
A total of 57 eligible individuals were invited to participate during the outpatient 
clinic visits, but only 51 were included in the study since 4 refused to partake, while the 
remaining 2 failed to produce valid EBC samples. During the football practice 
recruitments, all 13 elements of the football team that were eligible to participate accepted 
the invitation. Therefore, a total of 64 participants aged 6 to 18 years were included in the 
study. For convenience, this sample of individuals shall be referred as “breathomics 
population” throughout the thesis. Figure 3 summarizes the recruitment flow of 
participants. 
The study was approved by the Ethics Committee for Health of S. João Hospital 
Centre (authorized at 14 April 2016) and by the National Data Protection Agency (nº 
5057/2016).  
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Figure 3 - Flow of participants through the study according to STARD (Bossuyt et al., 2015). 
 
4.2 Clinical and physiological assessments 
A summary of the study outcomes and instruments is shown in Table 5. 
 
Table 5 - Summary of study outcomes and biomarkers (studies I, II and IV). Medical diagnosis by an 
allergologist has also been performed in study IV. 
 
Outcome Biomarkers and instruments Study Reference 
Lung function Spirometry, Spirobank (MIR, Italy) I, II, IV (Miller et al., 2005) 
Airway inflammation Exhaled NO, NObreath (Bedfont Scientific 
Ltd., UK) 
I, II (Dweik et al., 2011) 
Allergic sensitization SPT, QuickTestTM applicator with allergen 
batch (Hall Allergy, Netherlands) 
I, II, IV (Global Initiative for 
Asthma, 2017) 
Autonomic nervous 
function 
Pupillometry, PLR-200™ Pupillometer 
(NeurOptics Inc, CA, USA) 
II (Muppidi et al., 2013, 
Stang et al., 2016) 
History of symptoms Standardized questionnaire based on ISAAC’s I, II (Asher et al., 1995) 
Exhaled VOCs EBC,  Turbo14 DECCS condenser system 
(Medivac, Parma, Italy)   
IV (Montuschi, 2007) 
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4.2.1 Physiological evaluation in schools (studies I and II) 
Children’s lung function and airway reversibility were assessed according to the 
ATS/ERS guidelines (Miller et al., 2005). Lung function data was retrieved before and 15 
minutes after administering 400 μg of inhaled salbutamol.  
Eosinophilic airway inflammation was assessed by measuring exhaled NO levels 
using the NObreath (Bedfont Scientific Ltd. UK). The results were expressed as parts per 
billion (ppb) and stratified according to the official ATS guidelines for children (Dweik et 
al., 2011). 
Allergic sensitization was evaluated by SPT on their forearm using a QuickTestTM 
applicator and extracts of Dermatophagoides pteronyssinus, weed pollen mix (Urtica 
dioica, Plantago lanceolate and Artemisia vulgaris), grass pollen mix (Agrostis 
stolonifera, Anthoxathum odoratum, Dactylis glomerata, Lolium perenne, Arrhenatherium 
elatius, Festuca rubra, Poa pratensis, Holcus lanatus, Phleum pratense, Secale cereal), cat 
dander, dog dander and Alternaria alternata, negative control (extracts dilutant), and a 
positive control (histamine at 10mg/mL), all belonging to the same batches (Hall Allergy, 
Netherlands). Results were read 20 minutes afterwards. If children were on antihistamines 
or topical corticosteroids on the skin within the previous 7 days, SPTs were postponed. 
Regarding pupillometry, the participants spent 15 minutes in a semi-dark and quiet 
room to allow their eyes to adjust to the low lighting levels before measurement. Pupillary 
measurements were taken with the portable infrared PLR-200™ Pupillometer (NeurOptics 
Inc, CA, USA). The complete pupillometry methodology has been thoroughly described in 
previous publications (Couto et al., 2015, Stang et al., 2016). Shortly, the pupil 
constriction response to a light stimulus represents parasympathetic activity, and the 
dilatation represents sympathetic activity. The following parameters were recorded: 
percentage of pupil constriction (CON); average and maximum constriction velocities 
(ACV and MCV, respectively); minimum and maximum pupil diameter; average dilation 
velocity (ADV); and the time in seconds at 75% recovery of pupil size (T75). Since there 
was no side-to-side difference in pupil responses, all pupillary data reported in the results 
was obtained from the right eye, in a similar approach to Muppidi et al. (2013). If a valid 
measurement was not obtainable, measurements from the left eye were used instead. 
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4.2.2 Clinical evaluation of the breathomics population (study IV) 
For the paediatric population recruited during study IV, bronchodilation was 
stimulated by administering 400 μg of inhaled salbutamol, and post-bronchodilator 
spirometry was performed 20 minutes afterwards. Allergic sensitization was evaluated by 
SPT on the participant’s forearm with extracts of Dermatophagoides pteronyssinus, 
Dermatophagoides farinae, weed pollen mix, grass pollen mix, dog dander and Alternaria 
alternata, negative control (extracts diluent), and a positive control (histamine at 
10mg/mL), all belonging to the same batches (CBF-LETI S.A., Madrid, Spain). Results 
were read 15 minutes afterwards. Information on medical diagnosis of asthma, rhinitis and 
atopic dermatitis was retrieved for each participant. 
The Turbo 14 DECCS condenser system (Medivac, Parma, Italy) was used to collect 
EBC samples from included participants (Montuschi, 2007). The device was cooled to 0 ºC 
prior to collection, in accordance with manufacturer’s instructions. EBC samples were 
obtained by at least 15 minutes of normal breathing while wearing a nose clip. Generally, 
800 to 1500 µL of EBC was collected from each subject being a volume of at least 600µL 
stipulated as the minimal requirement for a valid sample. The different sample volumes are 
associated with the children’s tidal and minute volumes of the lungs (Liu and Thomas, 
2007). 
After collection, samples were transferred to capped glass tubes and stored at -80 ºC 
until analysis. This procedure was performed in controlled environment through a laminar 
flow cabinet to decrease possible sample contamination by environmental air. 
 
4.3 Definition of clinical and exposure outcomes 
4.3.1 Clinical definitions for the school survey (studies I and II) 
For the children recruited and evaluated at the 20 participating schools, the following 
operational asthma definitions were adopted: i) Clinical criteria – at least a 12% and over 
200mL increase in FEV1 after bronchodilation and/or self-report of asthma diagnosed by a 
physician with reported symptoms (wheezing, dyspnoea or dry cough) occurring in the 
past 12 months; ii) Functional criteria – at least a 12% and over 200mL increase in FEV1 
after bronchodilation; iii) Treated asthma – self-report of asthma diagnosed by a physician 
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and currently under inhaled corticosteroid treatment; and iv) Ever asthma – self-report of 
asthma diagnosed by a physician. 
Allergic sensitization was defined by a positive SPT to at least one of the tested 
allergens (wheal > 3mm) coupled to a positive histamine response (wheal > 3mm) and no 
positivity in the negative control (wheal < 3mm) (Global Initiative for Asthma, 2017). 
Atopic eczema was defined as a positive answer to the question “Did your child ever 
had itchy skin alterations that appeared and disappeared for at least 6 months, during the 
past 12 months?” followed by a positive answer to “Did these skin alterations ever affected 
elbow and knee joints, ankles, between thighs, or around the neck, ears or eyes?”, based on 
the UK Working Party diagnostic criteria for the definition on atopic eczema (Williams et 
al., 1994). Otitis definition was based on a positive answer to the question “Did your child 
had ear pain or otitis in the last 12 months not associated with a cold or a flu?”, while 
allergic rhinitis was defined as a positive answer to the question “Did your child suffer 
from recurrent sneezing, runny nose or nasal congestion, in the past 12 months, not 
associated with a cold or a flue?”. 
 
4.3.2 Reference standard for the breathomics survey (study IV) 
Information on medical diagnosis of asthma, rhinitis and atopic dermatitis were 
retrieved for each participant of the breathomics population. The reference standard was 
the medical diagnosis of asthma, based on the spirometry with bronchodilation challenge 
results, as well as symptoms history and physical examination, according to the Global 
Initiative for Asthma guidelines (Global Initiative for Asthma, 2017). 
Participants diagnosed with asthma and under maintenance inhaled steroid therapy 
were classified as having persistent asthma, while individuals with asthma simply under 
reliever inhaled therapy were regarded as having intermittent asthma. Medical diagnosis of 
allergic rhinitis and atopic dermatitis was based on the allergic sensitization results as well 
as symptoms history and physical examination.    
 
4.3.3 Swimming pool attendance and extracurricular sports (study II) 
According to the questionnaire answers, subjects were defined as current swimmers 
(CS) if parents answered “Yes” to the question: “Does your child swim frequently in an 
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indoor swimming pool (at least once per week)?”; if they answered “No, but he/she used 
to”, participants were classified as past swimmers (PS); otherwise, if they answered “No”, 
they were regarded as non-swimmers (NS). For the CS and PS groups, cumulative 
swimming pool exposure, expressed in years, was calculated. The question “Does your 
child partake in any sport activity outside of normal school-period, at least once per 
week?” was used to scrutinize if non or past swimmers practiced any other type of 
extracurricular sport, in order to exclude any conceivable bias associated with sedentarism 
or training volume. Figure 4 illustrates the recruitment flow and group selection criteria. 
 
 
Figure 4 - Flow chart of the recruited participants (study II). Round-edged boxes represent the 
questions that allowed classification of participants into three different groups according to the 
respective answers (Cavaleiro Rufo et al., 2018).  
 
4.4 Microorganism sampling (study I) 
Bacterial and fungal air samples were collected in the 71 participating classrooms 
using a single-stage microbiological air impactor (Merck Air Sampler MAS-100), 
according to NIOSH method 0800 (National Institute for Occupational Safety and Health, 
1998) and the European Standard 13098 (European Standards, 2000). Tryptic Soy Agar 
(supplemented with 0.25% cycloheximide) and Malt Extract Agar (supplemented with 1% 
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of chloramphenicol) were used as culture media for bacteria and fungi, respectively. Air 
was drawn through the sampler at 100 L/min and sequential duplicate air samples of 250 L 
were collected. A total of 2 Tryptic Soy Agar and 2 Malt Extract Agar samples were 
collected per classroom. The mean colony-forming unit (CFU) values of duplicate samples 
were used as the final result in accordance with laboratory criteria. The volume and, 
consequently, the duration of sequential air sampling was the same in all schools and 
classrooms. In each sampling day, four field blanks, two sterility blanks, one positive and 
one negative control per culture medium were used. This methodology has been validated 
in other publications (Madureira et al., 2014, Madureira et al., 2015). 
Concurrently with bacteria and fungi assessment, indoor air LPS samples were 
collected during 4h with GilAir-5 flow control pumps (Sensidyne, USA) set to 2L/min and 
coupled to button aerosol stainless steel samplers (SKC, USA). 
 
4.5 Laboratory procedures 
4.5.1 Microbial analysis (study I) 
The bacterial and fungal samples collected in classrooms were incubated at 37±1 ºC 
for 48±3 hours and at 25±3 ºC for 72±3 hours, respectively (Madureira et al., 2014, 
Madureira et al., 2015). Quantiﬁcation of bacteria and fungi levels was performed by 
naked eye count following an internal procedure based on the methodologies expressed in 
European Standard 13098 (European Standards, 2000) and ISO 4833-1:2013 (International 
Organization for Standardization, 2013). The number of colonies recovered on the air-
sample plates was adjusted using a positive-hole correction factor and the results were 
expressed as number of colony-forming units per cubic metre of air (CFU/m3). The 
correction factor was based on Fellers law. The quantiﬁcation limit was established as 10 
CFU per plate. 
Specific fungal identification was performed 7 days after incubation, either on the 
original sampling medium plates or after subculturing procedures, whenever colony 
isolation and growth observation were needed. Identification of fungal colonies was based 
upon phenotypic characteristics and followed standard mycological procedures based on 
their micro and macro-morphological characteristics.  
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For endotoxin extraction, sampling filters were eluted in 5 ml extraction solution 
(Pyrogen Free Water plus 0.05% Tween 20) and rocked vigorously for 1 hour at room 
temperature on a horizontal shaker. After 10 minutes of centrifugation at 1000 g, total 
supernatant per sample was collected and analysed. Endotoxin quantification was 
performed using the limulus amebocyte lysate (LAL) Kinetic-QCLTM (Lonza®, 
Pontevedra, Spain) following the manufacturer’s guidelines. Endotoxin concentrations 
were expressed as EU/m3. The limit of detection for the LAL Kinetic-QCLTM is 0.005 
EU/mL, corresponding to 0.025 EU/m3 under the adopted procedure. 
 
4.5.2 Exhaled VOC analysis by electronic nose (study IV) 
 To measure breathprints in EBC samples, the Cyranose® 320 (Sensigent, California, 
USA) eNose was used. This is a handheld device capable of detecting patterns of VOCs 
through 32 chemical sensors based on conducting chemoresistors made from carbon black 
nanocomposites. More information on Cyranose® 320 may be found in the exhaled breath 
analysis by electronic nose section of the literature review (section 2.2.3). The settings 
used for the current study are presented in Table 6. 
 
Table 6 - Cyranose® 320 settings for EBC analysis. 
 
Samples were defrosted at ambient temperature prior to processing. The whole 
measurement procedure was conducted in a laminar flow cabinet to prevent ambient air 
Setting Time Speed 
Baseline purge 10s Medium 
Sample draw 1 10s Medium 
Sample draw 2 0s n.a. 
Snout removal 10s n.a. 
1st sample gas purge 20s High 
1st air intake purge 30s High 
2nd sample gas purge 20s High 
2nd air intake purge 0s n.a. 
n.a.: not applicable   
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contamination and the cabinet’s temperature and relative humidity were continually 
measured. For VOC analysis, 600 µl of EBC was transferred to 12x75mm glass assay 
tubes which were then covered with laboratory film. The tubes were subsequently heated 
in dry bath at 37 ºC for 2 minutes to increase the gas phase and an exhaust was created in 
the laboratory film, as previously described (Hüttmann et al., 2011). Afterwards, a 20 g 
needle was attached to the Cyranose® 320 snout and used to pierce the laboratory film 
while holding the device above the surface. The laminar flow cabinet’s air was used as 
reference air while baselining for 10 seconds and then a sample was drawn for another 10 
seconds. This procedure was repeated for all samples. 
 
4.6 Construction of a breathomics model (study IV) 
The 32 sensor resistance values provided by the eNose were retrieved and imported as 
a dataframe object to the R software v3.4.2 (R Foundation, Vienna, Austria) through the 
RStudio interface v1.0.153 (RStudio INC., Massachusetts, USA). In a first step, principal 
component analysis (PCA) was applied for exploratory observation of the data dimension 
and distribution (Figure 5).  
 
 
Figure 5 – Spatial distribution of the eNose sensor resistance values based on two components, after 
principal component analysis.   
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To assess clustering tendency, the Hopkin’s index was calculated and a dissimilarity 
matrix was drawn (Figure 6). Since the Hopkin’s statistic retrieved a value of 0.89, data 
was considered as highly clusterable (Banerjee and Dave, 2004).  
 
 
Figure 6 – Dissimilarity matrix of the eNose sensor data. The agglomerated colours suggest highly 
clusterable data. 
 
 
Internal validation and cluster stability methods were performed and optimal scores 
where achieved in both cases through hierarchical clustering with k=2. To further confirm 
the optimal number of clusters, the total within sum of squares and the average silhouette 
width methods were applied. Both methods confirmed the optimal cluster score of k=2 
(Figure 7 and 8). Therefore, a hierarchical model with two clusters was created using the 
32 sensor resistance values, blinded to the reference standard results (Figure 9). 
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Figure 7 - Total within sum of squares (elbow) method for determining optimal number of clusters. 
The “elbow” of the curve indicates the suitable number of clusters for a given dataframe. In this case, 
the elbow bends at k=2, suggesting that data may be grouped in two different clusters. 
 
 
 
 
Figure 8 - Silhouette method for determining optimal number of clusters. The peak of the curve 
indicates the suitable number of clusters for a given dataframe. In this case, the curve peaks at k=2, 
suggesting that data may be grouped in two different clusters. 
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Figure 9 – Heatmap representing data divided in two clusters (A and B) based on hierarchical 
multivariate analysis. 
 
4.7 Data processing and statistical analysis (studies I – IV) 
The SPSS® statistical package software v20.0 (IBM, New York, USA) was used to 
statistically analyse the data in study I and II, as well as to perform t-student and chi-square 
tests between the two clusters of the hierarchical model, conducting discriminant analysis, 
and calculate the accuracy, sensitivity, specificity and areas under ROC curves in study IV. 
The meta-analysis in study III was performed using the Stata IC software v13.0 (StataCorp 
LP, Texas, USA) and the Meta-DiSc software v1.4 (Clinical BioStatistics Unit, Madrid, 
Spain) (Zamora et al., 2006).  
The Kolmogorov-Smirnov test was used to check continuous variables for normality 
in studies I and II. In study IV, the Shapiro-Wilk test was used instead due to the smaller 
sample size. Whenever non-Gaussians distributions were observed, non-parametric tests 
were used for inferential analysis. Significant differences were reported with an α-value 
inferior to 5% (p<0.05), when applicable. 
When analysing the specific fungi species in study I, each species’ proportions were 
generally categorized into terciles. Since in some cases the detected levels were very low, 
such as the case of Acremonium spp, the variable was dichotomised with the lower 
category consisting in values under the limit of detection, while the higher category 
included those over the detection limit. A microbial diversity score was defined as the sum 
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of all detected fungi groups/species in a given classroom. The variable was categorized 
into quartiles, being the classrooms with lower diversity score in the 1st quartile, whereas 
the 4th quartile included those with higher diversity scores. Logistic regression adjusted for 
age and height was used to analyse the risk for allergic sensitization and asthma associated 
with the collected indoor air microbiology (total and specific values). Multinomial logistic 
regression was used for analysing the risk of inflammation reported by exhaled NO. The 
results were expressed as odds ratio (OR) and respective 95% confidence interval (95% 
CI). 
To analyse the data concerning study II, the t-student test and one-way ANOVA (for 
normal distributions) or Mann-Whitney and Kruskal-Wallis tests (for non-parametric 
distributions) were used to compare continuous variables between two or more than two 
groups of individuals, respectively. The Spearman’s correlation test was used to find 
correlations between the number of years in swimming practice and the measurable 
outcomes. Logistic regression analysis was then used to find associations between the 
number of years in swimming practice and the binary categorical variables, with results 
expressed in β [95% CI]. 
In the meta-analysis of the systematic review (study III), the sensitivity and specificity 
of the included studies were used to construct a contingency table. The bivariate meta-
analysis model was employed to obtain the pooled value of sensitivity, specificity, positive 
likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR) and 
generate the bivariate summary ROC curve. Heterogeneity between studies was evaluated 
using the chi-square and I2 tests. As previously mentioned, a value of p<0.05 was 
considered as being statistically significant, while I2 ≥50% indicated the existence of 
significant heterogeneity (Higgins et al., 2003, Dinnes et al., 2005). For the purpose of 
threshold effect detection, and to evaluate the relationship between sensitivity and 
specificity, the Spearman’s correlation test was used. Publication bias of the selected 
studies was assessed using Begg’s funnel plot and Egger’s test (Borenstein et al., 2009). 
T-student test was used to find if there were differences in participants’ characteristics 
between groups, for continuous variables, in study IV. Chi-square tests were used for 
inferential statistics between two categorical variables and risk estimation was performed 
to assess the tendency of asthma severity according to each cluster of the hierarchical 
model. Discriminant analysis was performed to identify the most relevant variables in the 
model. Receiver operating characteristic curves were built and accuracy, sensitivity, 
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specificity and AUC values were calculated according to standardized methods (Baratloo 
et al., 2015, Carter et al., 2016). 
 
4.8 Ethics 
The studies’ protocols were authorized by the Ethics Committee for Health of S. João 
Hospital Centre (studies I, II and IV), the schools’ Directive Councils (studies I and II), 
and by the National Data Protection Agency (study IV). The recruitment process of study 
IV was registered in the Clinical Trials platform under the registry number 
“NCT02802891”. Parents or legal guardians of participating children (studies I, II and IV) 
provided their signed informed consent, while subjects that were aged 18 (study IV) signed 
their own. 
The adaption and reproduction of any material retrieved from published manuscripts 
was authorized by the copyrights holder. 
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5 Results 
5.1 Participants 
5.1.1 Children assessed at school (studies I and II) 
The characterization of the participants recruited for studies I and II is presented in 
Table 7. Prevalence of asthma diagnosed by clinical criteria, functional criteria, treated 
asthma and ever asthma was 9.3, 6.6, 5.4, and 6.3%, respectively. Prevalence of allergic 
sensitization was 34.1%. The prevalence of allergic rhinitis and atopic dermatitis was 10.6 
and 9.3%, respectively. 
 
Table 7 – Characteristics of participating children evaluated at school (studies I and II).  
  Total (n= 858) Female (n= 427) Male (n= 431) 
Age (years, mean ± sd) 9 ±1 9 ±1 9 ±1 
Weight (kg) 31.2 (27.3 – 37.2) 31.8 (27.0 – 37.3) 30.8 (27.5 – 36.8) 
Height (cm) 135 (130 – 140) 135 (130 – 139) 135 (130 – 140) 
BMI (kg/m2) 17.0 (15.5 – 19.5) 17.3 (15.6 – 19.8) 16.8 (15.5 – 19.2) 
Clinical parameters    
Allergic sensitization (n) 293 139 154 
Allergic rhinitis (n) 91 37 54 
Atopic eczema (n) 80 37 43 
Asthma prevalenceβ    
Clinical criteria (%) 9.3 11.5 7.2 
Functional criteria (%) 6.6 8.2 5.1 
Treated asthma (%) 5.4 6.1 4.6 
Ever asthma (%) 6.3 6.8 6.2 
Lung function    
FVC (L) 1.89 (1.69 – 2.14) 1.83 (1.66 – 2.08) 1.94 (1.72 – 2.18) 
FEV1 (L) 1.75 (1.58 – 1.95) 1.71 (1.55 – 1.92) 1.77 (1.59 – 1.99) 
FEV1/FVC (%) 92.7 (88.9 – 96.4) 93.2 (89.8 – 96.6) 92.0 (88.0 – 96.1) 
FEF25-75 (L/s) 2.28 (1.92 – 2.65) 2.28 (1.93 – 2.64) 2.29 (1.91 – 2.68) 
FEV1 reversibility (%) 3.5 (0.0 – 7.1) 3.7 (0.0 – 7.2) 3.5 (0.5 – 7.0) 
FEV1 reversibility (ml) 60 (0 – 120) 60 (0 – 120) 60 (10 – 130) 
Exhaled NO (ppb) 11.0 (6.0 – 20.0) 9.5 (5.0 – 16.0) 12.0 (6.0 – 22.5) 
Data reported as median (25-75%) unless otherwise stated. BMI: body mass index; FEV1: forced expiratory volume in the first second of 
FVC; FVC: forced vital capacity; FEF25-75: forced expiratory flow middle portion of FVC. βThe following operational asthma definitions 
were adopted: i) Clinical criteria – at least a 12% increase in FEV1 after bronchodilation and over 200mL and/or asthma diagnosed by a 
physician with reported symptoms (wheezing, dyspnoea or dry cough) occurring in the past 12 months; ii) Functional criteria – at least a 
12% increase in FEV1 after bronchodilation and over 200mL; iii) Treated asthma criteria – asthma diagnosed by a physician and 
currently under inhaled corticosteroid treatment; and iv) Ever asthma – asthma diagnosed by a physician. 
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In the framework of study II, the school population characterized above was further 
separated into three groups according to swimming practice, as described in the 
methodology section (4.3.3). Due to incomplete or unanswered questionnaires, 83 
participants were excluded from the study. Therefore, a total of 205, 228 and 342 children 
were classified as CS, PS and NS, respectively (Table 8 and 9). 
 
Table 8 – Physiological parameters of participants according to swimming pool attendance (study II). 
Parameters Current swimmers Past swimmers Non-swimmers p 
N (males) 205 (99) 228 (115) 342 (175) - - 
Age (years, mean ± sd) 8.7 ±0.8 8.6 ±0.7 8.9 ±0.8 0.011¥ 
Weight (kg) 30.9 (26.6 to 36.9) 32.1 (28.2 to 37.8) 30.8 (26.9 to 37.3) 0.048 
Height (cm) 135 (130 to 139) 136 (131 to 141) 136 (131 to 141) 0.196 
Sport practisers (%) 100.0 98.3 98.2 0.965 
Lung function     
FVC (L) 1.88 (1.71 to 2.15) 1.91 (1.71 to 2.18) 1.88 (1.66 to 2.10) 0.125 
FEV1 (L) 1.73 (1.58 to 1.95) 1.78 (1.60 to 1.99) 1.74 (1.55 to 1.92) 0.081 
FEV1/FVC (%) 92.8 (89.1 to 96.1) 92.5 (89.0 to 96.6) 92.7 (88.8 to 96.4) 0.998 
FEF25-75 (L/s) 2.23 (1.97 to 2.71) 2.36 (1.93 to 2.71) 2.27 (1.91 to 2.59) 0.423 
PEF (L/s) 3.77 (3.30 to 4.38) 3.77 (3.38 to 4.21) 3.69 (3.27 to 4.27) 0.641 
FEV1 reversibility (mL)  70 (20 to 130) 60 (10 to 120) 60 (-10 to 110) 0.028 
FVC reversibility (mL) 40 (-30 to 100) 30 (-30 to 80) 20 (-40 to 90) 0.219 
Exhaled NO (ppb) 12 (7 to 20) 11 (6 to 20) 10 (5 to 19) 0.086 
Asthmaβ     
Clinical criteria (n, %) 11.7% 8.3% 9.4% 0.459* 
Functional criteria (n, %) 6.3% 7.0% 6.4% 0.957* 
Treated asthma (n, %) 6.3% 4.0% 6.1% 0.441* 
Ever asthma (n, %) 7.3% 4.8% 7.3% 0.438* 
Atopic eczema (n, %) 66.7% 62.9% 54.4% 0.465* 
Allergic rhinitis (n, %) 33.3% 33.8% 31.1% 0.907* 
Allergic sensitization (%) 32.8 39.5 34.2 0.302* 
Otitis (n, %) 27.0% 21.0% 32.4% 0.043* 
Data reported as median (P25 to P75) unless otherwise stated. BMI: body mass index; FEV1: forced expiratory 
volume in the first second of FVC; PEF: Peek expiratory flow; FVC: forced vital capacity; FEF25-75: forced 
expiratory flow middle portion of FVC; EBC: exhaled breath condensate. The p values signalling differences 
between the three groups were calculated using the Kruskal-Wallis test for non-parametric variables, with the 
exception of cases marked with (*) which were calculated using qui-square tests, and (¥), which were calculated 
using one-way ANOVA (for normal distributions).  
βThe following operational asthma definitions were adopted: i) Clinical criteria – at least a 12% increase in FEV1 
after bronchodilation and over 200mL and/or asthma diagnosed by a physician with reported symptoms (wheezing, 
dyspnoea or dry cough) occurring in the past 12 months; ii) Functional criteria – at least a 12% increase in FEV1 
after bronchodilation and over 200mL; iii) Treated asthma criteria – asthma diagnosed by a physician and currently 
under inhaled corticosteroid treatment; and iv) Ever asthma – asthma diagnosed by a physician. 
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Table 9 – Pupillometry parameters of participants according to swimming pool attendance (study II). 
Pupillometry parameters Current swimmers Past swimmers Non-swimmers p 
Maximum (mm, mean ± sd) 5.2 ±0.9 5.3 ±1.0 5.3 ±0.8 0.278 
Minimum (mm, mean ± sd) 3.4 ±0.6 3.4 ± 0.6 3.4 ±0.6 0.537 
CON (%, mean ± sd) 35 ±5 36 ±5 36 ±5 0.203 
ACV (mm/s, mean ± sd) 3.8 ±0.7 3.9 ±0.8 4.0 ±0.7 0.030 
MCV (mm/s, mean ± sd) 5.1 ±1.0 5.3 ±1.0 5.4 ±0.9 0.010 
ADV (mm/s, mean ± sd) 1.2 ±0.3 1.2 ±0.4 1.2 ±0.3 0.709 
T75 (s, mean ± sd) 1.7 ±0.7 1.7 ±0.7 1.7 ±0.7 0.987 
CON: percentage of pupil constriction; ACV: average constriction velocity; MCV: maximum conscription velocity; 
ADV: average dilation velocity; T75: time in seconds at 75% recovery of pupil size 
The p values signalling differences between the three groups were calculated using one-way ANOVA. Significant 
differences in bold. 
 
5.1.2 Breathomics population in two clusters (study IV)  
The exhaled VOC-based hierarchical model was able to significantly discriminate 
individuals with asthma from those without the disease, in the two clusters (p<0.001). In 
addition, persistent asthma cases, which were individuals who had been administered 
inhaled corticosteroid medication, were also significantly distinguished in the model 
(p<0.001). Consequently, 100% of positive bronchodilation challenges were reported in 
the same cluster (p<0.001). However, exhaled VOC analysis was unable to discern patients 
with allergic rhinitis and atopic dermatitis from those without these conditions (p=0.511 
and p=0.623, respectively). A summary of these results is presented in Table 10. 
Discriminant analysis showed that the highest correlation between the hierarchical 
model and standardized canonical discriminant functions was achieved by persistent 
asthma variable (rho=0.602), followed by spirometry with bronchodilation (rho=0.544). 
These results show that the analysed exhaled VOC profiles were hierarchised mainly 
according to the asthma severity status of the patients, with those needing inhaled 
medication (persistent asthma) presenting significantly different VOC profiles from those 
with intermittent asthma or without asthma at all (Table 11). 
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Table 10 - Differences between the hierarchical model clusters, created using the 32 sensor resistance 
values measured by the eNose, according to participants’ characteristics. 
 
 
 
Table 11 - Pooled within-groups correlations between discriminating variables and standardized 
canonical discriminant functions. Variables are ordered by absolute size of correlation within function. 
 
Discriminating variables rho* 
Persistent asthma 0.602 
Bronchodilation 0.544 
Weight 0.156 
Age 0.146 
Height 0.134 
Intermittent asthma -0.077 
Skin prick tests -0.052 
Allergic rhinitis -0.042 
Sex 0.035 
Atopic dermatitis -0.028 
Recruitment setting -0.009 
*Correlation coefficient for standardized canonical discriminant functions 
 
 Characteristics Cluster A Cluster B p 
n (males) 26 (17) 38 (24) 0,855 
Age (years, mean ± sd) 10,7 (±3,5) 12,1 (±3,1) 0,223* 
Height (cm, mean ± sd) 148,2 (±19,3) 155,2 (±15,2) 0,050* 
Weight (kg, mean ± sd) 43,3 (±15,4) 51,4 (±14,9) 0,920* 
Positive BD (n) 0 20 <0,001 
Positive SPT (n) 22 29 0,418 
Medical diagnosis of asthma (n) 10 35 <0,001 
Intermittent asthma (n) 8 8 0,378 
Persistent asthma (n) 2 27 <0,001 
Allergic Rhinitis (n) 21 28 0,511 
Atopic dermatitis (n) 3 3 0,623 
p values in bold correspond to significant differences between clusters. Differences calculated through qui-
square tests, except for continuous variables (marked with *), which were calculated through t-student tests.  
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5.2 Influence of classroom microbial diversity on asthma and 
allergic sensitization risk in children (study I)  
Classrooms with 2nd tercile (OR = 1.26 [95% CI: 0.88 – 1.79]) and 3rd tercile (OR = 
1.40 [95% CI: 0.99 – 1.99]) concentrations of LPS showed a tendency for a higher risk of 
allergic sensitization (Figure 10A). Moreover, classrooms with higher concentrations of 
LPS had a significantly higher prevalence of allergic children (2.20 [0.89 – 4.25] vs 2.60 
[1.18 – 5.68], data presented as median [25% - 75%], respectively non-sensitized vs 
sensitized, p=0.02). On the other hand, no tendencies were observed for asthma. 
Diversity scores ranged from 1 to 11. Logistic regression models showed a negative 
association between the diversity of fungal species in classrooms and the risk of allergic 
sensitization (Figure 10B). These results were significant for the 3rd (0.63 [95% CI: 0.40 – 
0.98]) and 4th (0.60 [95% CI: 0.40 – 0.92]) quartile scores, which ranged from 7 to 8. 
 
 
Figure 10 - A: Logistic regression between LPS, bacterial and fungal exposure in classrooms and the 
prevalence of asthma and allergic sensitization. B: Logistic regression between fungal diversity scores 
and the prevalence of asthma and allergic sensitization. The results are expressed as odds ratios with 
95% CI in logarithmic scale. 
 
João Cavaleiro Rufo 
_________________________________________________________________________ 
46 
 
Additional pro-sensitization evidence was observed with specific fungal species, as 
classrooms with 2nd tercile concentrations of Penicillium spp were associated with a higher 
risk of sensitization (OR = 1.46 [95% CI: 1.02 – 2.09]) and classrooms with 3rd tercile 
concentrations showed an even higher risk (OR = 1.68 [95% CI: 1.18 – 2.40]). This 
tendency for a higher sensitization risk associated with Penicillium spp can be observed in 
Figure 11. On the other hand, classrooms with higher concentrations of Aspergillus 
fumigatus (3rd vs 1st tercile, OR = 0.64 [95% CI: 0.47 – 0.87]), Aspergillus niger (detected 
vs not-detected, OR = 0.62 [95% CI: 0.45 – 0.87]), Chaetomium spp (detected vs not-
detected, OR = 0.61 [95% CI: 0.39 – 0.96]) and Rhizopus spp (detected vs not-detected, 
OR = 0.62 [95% CI: 0.45 – 0.87]) were associated with a lower risk of allergic 
sensitization (Figure 11 and 12). Interestingly, the risk ratios were very similar between 
these species (children had 1.56 to 1.64 times less risk of being sensitized). 
 
Figure 11 – How fungal species influence allergic sensitization (first set). 
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Figure 12 - How fungal species influence allergic sensitization (second set). 
 
 
Unlike allergic sensitization, the classrooms’ specific fungal species and flora 
diversity were not associated as a risk factor for any of the 4 different definitions of asthma 
(Figure 13). Moreover, the higher tendency observed for functional asthma was not 
replicated for the other definitions.   
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Figure 13 – The risk of asthma, using 4 definitions, associated with fungal diversity in classrooms. The 
following operational asthma definitions were adopted: i) Clinical criteria – at least a 12% increase in 
FEV1 after bronchodilation and over 200mL and/or asthma diagnosed by a physician with reported 
symptoms (wheezing, dyspnoea or dry cough) occurring in the past 12 months; ii) Functional criteria – 
at least a 12% increase in FEV1 after bronchodilation and over 200mL; iii) Treated asthma criteria – 
asthma diagnosed by a physician and currently under inhaled corticosteroid treatment; and iv) Ever 
asthma – asthma diagnosed by a physician. 
 
5.3 Effects of swimming pool attendance in schoolchildren 
(study II)  
Children in the CS group had significantly lower MCV and ACV when compared to 
both PS and NS groups, MCV (mm/s, mean±sd): 5.1 ±1.0 vs 5.3 ±1.0 vs 5.4 ±0.9, 
respectively (p=0.010); and ACV(mm/s, mean±sd): 3.8 ±0.7 vs 3.9 ±0.8 vs 4.0 ±0.7, 
respectively (p=0.030). Moreover, levels of exhaled NO and changes in airway 
reversibility volume after administration of a beta-2 agonist were significantly higher in the 
CS group when compared to NS (respectively, median [P25 to P75]: 12ppb [7 to 20] vs 10 
ppb [5 to 19], p=0.030; and 70mL [20 to 130] vs 60mL [-10 to 110], p=0.007) (Table 8 and 
Figure 13). These results were not influenced by sedentarism and/or other sport practice 
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since no significant difference was found between percentage of weekly sport practisers 
between groups (p=0.965). 
There were no differences between the three groups of participants for the prevalence 
of asthma (for any of the 4 definitions) or allergic sensitization, although a significantly 
higher occurrence of otitis was observed in NS when compared to PS (32.4 vs 21.0%, 
respectively; p=0.013), but not to CS (32.4 vs 27.0%, respectively; p=0.251).  
 
 
Figure 14 - Median (with 25 and 75 percentiles) levels of exhaled NO and FEV1 reversibility, and mean 
±SD of measured ACV and MCV among the three groups. CS – current swimmers; PS – past 
swimmers; NS – non-swimmers. *Represents significant differences between two groups indicated by 
the extremities of the horizontal line (p<0.05) (Cavaleiro Rufo et al., 2018). 
 
 
Differences found in the studied physiological outcomes were not influenced by the 
inclusion of individuals with asthma in the groups since, with the exception of atopic 
eczema, there were no significant changes when exclusively comparing individuals with 
clinical defined asthma (Table 12). 
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Table 12 - Clinical parameters of individuals with asthma, between the three groups. For this analysis, 
participants with asthma were selected according to the clinical criteria: at least a 12% increase in 
FEV1 after bronchodilation and over 200mL and/or asthma diagnosed by a physician with reported 
symptoms (wheezing, dyspnoea or dry cough) occurring in the past 12 months. 
 
 
Current swimmers Past swimmers Non-swimmers p 
N (males) 24 (10) 19 (8) 23 (9) - - 
Age (years, mean ± sd) 8.9 ±1 8.7 ±0.7 8.8 ±0.8 0.640¥ 
Weight (kg) 33.1 (31.0 to 37.1) 32.3 (28.9 to 37.5) 30.7 (26.6 to 39.5) 0.514 
Height (cm) 136 (133 to 140) 135 (132 to 141) 135 (129 to 138) 0.587 
Sport practisers (%) 100.0 100.0 96.9 0.506 
Allergic sensitization (%) 45.8 38.9 46.9 0.852* 
Lung function     
FEV1 (L) 1.69 (1.50 to 1.95) 1.72 (1.53 to 1.89) 1.64 (1.38 to 1.81) 0.608 
PEF (L/s) 3.54 (3.27 to 4.38) 3.62 (3.17 to 3.77) 3.66 (2.86 to 3.93) 0.667 
FVC (L) 1.87 (1.67 to 2.07) 1.95 (1.69 to 2.08) 1.86 (1.58 to 2.05) 0.473 
FEF25-75 (L/s) 2.13 (1.67 to 2.79) 1.90 (1.62 to 2.62) 2.01 (1.63 to 2.59) 0.535 
FEV1/FVC (%) 92.8 (87.6 to 96.0) 87.1 (83.5 to 94.1) 92.2 (85.3 to 96.9) 0.283 
FEV1 reversibility (mL)  22 (5 to 27) 23 (21 to 33) 22 (11 to 30) 0.388 
FVC reversibility (mL) 11 (3 to 23) 19 (3 to 28) 18 (2 to 24) 0.636 
Exhaled NO (ppb) 20 (12 to 45) 15 (8 to 28) 20 (4 to 42) 0.572 
Otitis (n, %) 35.3% 26.7% 30.8% 0.870* 
Atopic eczema (n, %) 100% 83.3% 33.3% 0.048* 
Allergic rhinitis (n, %) 41.7% 50.0% 45.8% 0.916* 
Pupillometry     
Maximum (mm, mean ± sd) 5.2 ±1.1 5.3 ±0.8 5.3 ±0.7 0.908¥ 
Minimum (mm, mean ± sd) 3.4 ±0.9 3.4 ± 0.5 3.4 ±0.5 0.932¥ 
CON (%, mean ± sd) 35 ±5 36 ±5 35 ±5 0.982¥ 
ACV (mm/s, mean ± sd) 3.6 ±0.8 3.9 ±0.7 4.0 ±0.7 0.166¥ 
MCV (mm/s, mean ± sd) 5.0 ±1.1 5.5 ±1.0 5.3 ±1.0 0.324¥ 
ADV (mm/s, mean ± sd) 1.2 ±0.3 1.0 ±0.2 1.1 ±0.3 0.146¥ 
T75 (s, mean ± sd) 2.0 ±0.7 1.7 ±0.9 1.7 ±0.6 0.444¥ 
Data reported as median (P25 to P75) unless otherwise stated. BMI: body mass index; FEV1: forced expiratory 
volume in the first second of FVC; PEF: Peek expiratory flow; FVC: forced vital capacity; FEF25-75: forced 
expiratory flow middle portion of FVC; EBC: exhaled breath condensate; CON: percentage of pupil constriction; 
ACV: average constriction velocity; MCV: maximum conscription velocity; ADV: average dilation velocity; T75: time 
in seconds at 75% recovery of pupil size. 
The p values signalling differences between the three groups were calculated using the Kruskal-Wallis test for non-
parametric variables, with the exception of cases marked with (*) which were calculated using qui-square tests, and 
(¥), which were calculated using one-way ANOVA (for normal distributions).  
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As expected, the number of years in swimming practice was significantly higher in CS 
when compared to PS (mean (±SD) = 3.9 (±2.2) vs 2.4 (±1.6), respectively; p<0.010). To 
investigate the effect of cumulative exposure resultant from swimming practice, 
correlations between the number of years in swimming practice and continuous variables 
of the measured health outcomes were calculated using the Spearman’s correlation test 
(Table 13). Significant correlations were observed for baseline FEV1 (rho=0.11), PEF 
(rho=0.18), and the CON (rho=0.12), ADV (rho= -0.13) and T75 (rho=0.19) parameters of 
pupillometry. Also, the logistic regression analysis showed a non-significant trend for a 
higher risk of asthma by lung function criteria (β [95% CI] = 1.13 [0.94 to 1.37]), atopic 
eczema (β [95% CI] = 1.15 [0.86 to1.53]) and allergic rhinitis (β [95% CI] = 1.10[0.89 to 
1.36]) with more years of swimming practice (Figure 15). 
 
Table 13 - Spearman’s correlation test between continuous clinical parameters and the number of 
years in swimming practice. Values represent the Spearman’s correlation coefficient. Significant 
correlations are expressed in bold. 
 
 
Number of years in swimming practice (rho) 
Lung function parameters 
FVC .098 
FEV1 .111 
FEV1/FVC -.001 
FEF 25–75% .054 
PEF .184 
Forced expiratory flow .008 
FEV1 reversibility .064 
Inflammatory parameters  
Exhaled NO .016 
Pupillometry parameters 
 
Maximum diameter .014 
Minimum diameter -.030 
CON .118 
ACV .013 
MCV -.001 
ADV -.126 
T75 .186 
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Figure 15 - Logistic regression between the number of years in swimming practice and the assessed 
clinical outcomes (adjusted for age). Results are represented as β (5-95%CI) (Cavaleiro Rufo et al., 
2018). 
5.4 Exhaled VOC analysis in asthma diagnosis (study III). 
Six studies retrieved from the systematic review presented sufficient data to be 
included in the meta-analysis (Dallinga et al., 2010, Montuschi et al., 2010, Ibrahim et al., 
2011, Caldeira et al., 2012, van der Schee et al., 2013, Smolinska et al., 2014). Sensitivity 
and specificity of exhaled VOC analysis in asthma diagnosis tests were retrieved from 
these studies and grouped according to the methodology used. For the purpose of the meta-
analysis, the methodology of analysis used (eNose or GC-MS) was not discriminated since 
it only represents different means to produce similar outcomes for diagnosing asthma 
through exhaled VOCs. Data retrieved from the aforementioned studies is presented in 
Table 14. 
The sensitivity and specificity values of the exhaled VOC analysis test for asthma 
diagnosis were analysed. Heterogeneity in specificity was observed among the 6 studies 
(I2=65.1%; p=0.014), which did not occur with sensitivity (I2=46.6%; p=0.095). Therefore, 
the random effects model was employed. The pooled results reported a mean (95% CI) 
sensitivity of 87% (82% to 91%) and specificity of 86% (80% to 90%). The mean (95% 
CI) pooled PLR was 5.86 (3.07 to 11.21), indicating that individuals with asthma had 
approximately 6 times higher chance of presenting asthma-associated exhaled VOC 
profiles when compared with individuals without asthma, and the mean (95% CI) pooled 
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NLR was 0.16 (0.10 to 0.26). The AUC was 0.94 and the mean (95% CI) pooled DOR was 
49.3 (15.9 to 153.3) (Figure 16 and 17, respectively). 
 
Table 14 - Studies included in the meta-analysis. 
 
 
 
Figure 16 - Summary receiver operating characteristics (SROC) curve for exhaled VOC analysis in 
asthma diagnosis. 
 
Reference Technique Sample size Accuracy Sensitivity Specificity 
(Montuschi et al., 
2010) 
Metalloporphyrins 
coated QMB sensor 
12 subjects with asthma 
vs 12 controls (analysis 
in alveolar exhaled 
breath) 
88% 100% 75% 
(van der Schee et 
al., 2013) 
Cyranose® 320 25 subjects with asthma 
and 20 controls (post-
steroid comparison) 
82% 84% 80% 
(Dallinga et al., 
2010) 
GC-MS 63 children with asthma 
vs 57 healthy controls 
92% 89% 95% 
(Ibrahim et al., 
2011) 
GC-MS 35 subjects with asthma 
vs 23 healthy controls 
86% 85% 89% 
(Caldeira et al., 
2012) 
GC-MS 32 children with allergic 
asthma vs 27 healthy 
controls 
98% 96% 95% 
(Smolinska et al., 
2014) 
GC-MS 76 children with asthma 
vs 50 healthy controls 
77% 82% 74% 
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Figure 17 - Forest plot of the pooled sensitivity, specificity and diagnostic odds ratio of exhaled VOC 
analysis in asthma diagnosis. 
 
5.4.1 Publication bias 
To assess publication bias, the Begg’s funnel plot and the Egger’s test were used 
(Figure 18). Both the funnel plot and the Egger’s test p-value (p=0.100) suggested no 
publication bias, although this observation is limited by the reduced number of studies 
included in the meta-analysis. 
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Figure 18 - Begg’s funnel plot for evaluation of publication bias in the selected studies. The funnel 
graph plots the log of the diagnostic odds ratio (DOR) against the standard error of the log of the DOR 
(an indicator of sample size). The Egger test for publication bias was not statistically significant (p = 
0.100), suggesting that there was no significant publication bias associated with the sample size. The 
dashed line represents Egger’s test regression. 
 
5.4.2 Diagnostic threshold and heterogeneity 
To evaluate the diagnostic threshold, the Spearman’s correlation coefficient between 
sensitivity and 1-specificity was calculated. The correlation coefficient was -0.429 
(p=0.397), suggesting that there was no heterogeneity from the threshold effect. Moreover, 
heterogeneity was also explored by meta-regression to assess the contribution by sample 
size, type of methodology used and the country were the study was performed. However, 
evidence of heterogeneity was not found for none of the aforementioned characteristics 
(p>0.05). 
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5.5 Diagnostic accuracy of eNose-based exhaled VOC analysis 
for paediatric asthma (study IV) 
Diagnostic accuracy measurements showed AUC values of 0.81 for both asthma 
diagnosis and persistent asthma diagnosis (p<0.001 in both cases), and achieved accuracy, 
sensitivity and specificity values ranging from 68.6 to 93.1%. Interestingly, although 
specificity values were generally lower, accuracy, sensitivity and AUC parameter values 
obtained from exhaled VOC analysis surpassed those from spirometry with 
bronchodilation in all cases. On the other hand, neither spirometry with bronchodilation or 
exhaled VOC analysis were useful in diagnosing intermittent asthma (AUC = 0.50 and 
0.56, p=1.000 and p=0.457, respectively). Table 15 summarizes the paediatric asthma 
diagnostic accuracy parameters measured for both exhaled VOC analysis and spirometry 
with bronchodilation challenge. 
Classification estimates showed a tendency to include individuals with asthma 
(OR=18.68; 95%CI: 4.50 to 77.24) and with a persistent disease (OR=29.50; 95%CI: 5.92 
to 146.50) in cluster B (Figure 19). 
 
 
Table 15 - Diagnostic accuracy parameters of the developed hierarchical model based on EBC VOC 
analysis through eNose in comparison with spirometry with bronchodilation. 
 
  Method 
Accuracy 
(%) 
Sensitivity 
(%) 
Specificity 
(%) 
AUC (CI 95%) p 
Asthma 
diagnosis 
BD 61.3 44.4 100 0.72 (0.60 - 0.84) 0.005 
eNose 79.7 77.8 84.2 0.81 (0.69 - 0.93) <0.001 
       
Intermittent 
asthma 
BD 59.4 31.3 68.8 0.50 (0.34 - 0.67) 1.000 
eNose 40.6 50 37.5 0.56 (0.40 - 0.73) 0.457 
       
Persistent 
asthma 
BD 70.3 51.7 85.7 0.69 (0.55 - 0.82) 0.010 
eNose 79.7 93.1 68.6 0.81 (0.70 - 0.92) <0.001 
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Figure 19 - Classification rates estimates between the two clusters of the hierarchical model. 
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6 Discussion 
6.1 Methodologic considerations 
Concerning the analysis of environmental determinants in classrooms and swimming 
pools (studies I and II), the main limitation resided in the cross-sectional design, which did 
not allow causal relationships to be established as a longitudinal study would. Specifically 
refering to the analysis of microbial determinants in paediatric asthma (study I), our 
observations considered only school-time exposure. While children spend most of their day 
at school, inside the classroom, they are still under exposure to microbiological agents in 
other environments when they sleep, or on the playground, during recess, therefore the 
complete exposome should be considered in future studies. Also, despite the fact that 
children in Portugal usually stay in the same classroom through primary school, this may 
not be true in other countries, resulting in more diverse exposure environments. 
Additionally, sensitization to one or more allergens does not necessarily imply a clinically 
relevant allergic status. Nevertheless, it was still possible to observe tendencies on how the 
prevalence of allergy and asthma in schoolchildren was affected by the exposure to indoor 
air bacteria and fungi in classrooms. Regarding the study focused on swimming pool 
exposure (study II), another limitation may be inherent to the question used to allocate 
participants to each group of swimming exposure, since although being “yes or no” 
questions, they are not exempt of reporting bias. Moreover, no data on number of hours of 
training per week has been considered for cumulative exposure assessment. However, 
considering the age range of participants, rarely should the practice represent more than 2 
hours per week of active swimming. We also cannot exclude reverse causation bias as the 
number of children with otitis was lower in past swimmers. 
Nevertheless, both studies (I and II) have several strengths. The substantial number of 
participants and classrooms involved provided good statistical power to the results, and the 
four distinct definitions of asthma may have prevented bias associated with the inclusion or 
exclusion of asymptomatic individuals. While concerning the microbial determinants 
(study I), diversity scores were calculated based on a large set of fungal species (24 in 
total), which enhanced the reliability of the obtained outcomes. On the other hand, the 
swimming pool exposure survey (study II) was community based, not affected by a 
swimming pool recruitment strategy bias, as children were recruited from 20 different 
schools. Moreover, the exclusion of sedentarism-based bias, coupled to the high number of 
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participants per group, as well as the extensive workup evaluation, particularly for 
assessing the autonomic nervous system and airway physiology, increased the robustness 
of the findings. Lastly, pupillometry is a sensible method that allows the detection of subtle 
changes in the oculosympathetic pathways, as previously demonstrated by Yoo et al. 
(2017) with the Horner’s eye syndrome (Yoo et al., 2017). These traits allowed the 
detection of asymptomatic alterations in parasympathetic tonus of children swimmers. 
Regarding the systematic review (study III), the sensitivity and specificity values were 
retrieved from studies using not only different analysis methods but also different 
algorithms for VOC profiling. Therefore, despite how much promising the meta-analysis 
results may seem to be, the standardization of volatilome analysis should be conducted. In 
common with all meta–analyses, this systematic review may have included studies in 
which the characteristics of the subjects were too dissimilar for comparison or the 
spectrum of included patients may have not been completely representative. Nevertheless, 
this was considered and reported on the quality rating of the included studies, with 
consideration of eventual publication bias (Attachment I). Secondly, included studies used 
different methodologies for assessing exhaled VOCs (mostly eNose and GC-MS) and, 
more importantly, used distinct VOC profiles for diagnosing individuals with asthma, 
making it impossible to further investigate how the diagnostic potential correlates with 
these characteristics due to the reduced number of trials available.  
There were also some limitations associated with the breathomics population 
recruitment design (study IV) such as the population size, since the total required 
population of 84 participants to surpass the 2.90 positive likelihood ratio reported for 
spirometry with bronchodilation was not achieved within its 95% confidence interval. 
Nevertheless, despite falling slightly short on individuals without asthma, the study 
managed to surpass the 42 mark for minimum individuals with asthma to be included, still 
reaching high sensitivity values. Another limitation may be associated with not separating 
individuals under different doses of inhaled corticosteroid therapy, which may have 
generated different OR values for the actual cluster according to the extent of airway 
inflammation. However, since the model was built blindly to the reference standard, the 
number of obtainable clusters would not change.  
Despite the aforementioned limitations, the breathomics study has several important 
traits. Although several studies focused on asthma diagnosis through eNose technologies 
have already been published (Rufo et al., 2016), most of these studies had either small 
sample sizes, biased analysis associated with the study design or statistical methods, 
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leading to methodologies inappropriate for real clinical application. In the present survey, 
recruitment was performed in two different settings, an outpatient allergy clinic and a 
football team training session, which hamper bias associated with the exclusive inclusion 
of individuals with allergic or respiratory conditions. Also, despite the fact that only 
football players were recruited during the training sessions, it was the variable that had the 
least influence on the model, thus showing that neither the recruitment setting or the 
participants’ exercise activities have interfered with asthma diagnosis results. Stability and 
internal validation methods were adopted prior to model construction to assess clustering 
tendency. Moreover, although an exploratory analysis was performed, through PCA, the 
model itself was constructed blindly to the diagnostic standards (the 32 eNose sensor 
resistance values were the only variables used to create the model), thus reducing possible 
bias associated with pre-labelled group comparisons. The STARD guidelines for reporting 
diagnostic accuracy were followed throughout the study, reducing eventual reporting bias 
(Bossuyt et al., 2015). The reference standard results for asthma diagnosis were provided 
by physician’s evaluation, according to standardized guidelines (Global Initiative for 
Asthma, 2017). Finally, breathomics were performed by eNose on EBC samples, which 
allowed the storage and freezing of samples, a considerably inexpensive 10 second per 
sample analysis, and the possibility of rapidly discriminating individuals with asthma, even 
in a hard-to-diagnose paediatric population. 
 
6.2 Environmental determinants in paediatric asthma 
6.2.1 The influence of microbial diversity exposure in classrooms (study I)  
Although the findings showed a clear tendency for decreased allergic sensitization 
with a more diverse exposure to fungal species, similar tendencies were not observed for 
asthma. Correspondingly, the increased risk of allergic sensitization that was found to be 
associated with higher levels of endotoxin or Penicillium spp was not detected for asthma. 
The enhanced risk of allergic sensitization with higher endotoxin exposure had 
already been expressed in the PASTURE study (Karvonen et al., 2012). These results need 
to be interpreted with caution, however, since children in the present study were 
considerably older and may have their immune systems further developed, thus the impact 
of exposure to endotoxin concentrations in this age group may be substantially different 
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than when exposition occurs in pre and post-natal periods of life. This may also justify 
why, unlike in previous studies (Braun-Fahrlander et al., 2002, Thorne et al., 2005, Ege et 
al., 2011, Mendy et al., 2011, Karvonen et al., 2012), exposure to environmental 
endotoxins had no significant associations with asthma prevalence. A further matured 
immune system may also be responsible for the distinct results regarding exhaled NO 
associations with microbiological parameters between the present work and the study 
performed by Casas et al. (2013), which showed that exhaled NO at school age was lower 
in children exposed to endotoxins during the first 2 to 3 months of life. Therefore, these 
results support that allergy and asthma have different responses to the same environmental 
determinants, and that a diverse exposure to these microbial agents appear to contribute to 
a preventive immunomodulation in children, inducing tolerance to allergens trough both 
adaptive and innate immune mechanisms (Cavaleiro Rufo et al., 2017b).   
While no particular fungal species were associated with any of the 4 definitions of 
paediatric asthma, the risk for allergic sensitization was significantly lower in classrooms 
with higher concentrations of some Aspergillus species, along with Chaetomium and 
Rhizopus species, thus supporting the results reported by Ege et al. (2011) in the 
framework of the GABRIELA study . On the other hand, classrooms with higher 
concentrations of Penicillium spp showed a significantly higher prevalence of allergic 
sensitization among children, which may correspond to similarly high cases of asthma 
onset later in life, thus corroborating the results obtained in a meta-analysis by Sharpe et 
al. (2015), where Penicillium species were found in significantly higher concentrations in 
the homes of individuals with asthma. It is possible that the higher sensitization is 
associated with the lower diversity scores in the respective classrooms, as high 
concentrations of Penicillium spp may extensively reduce the sustainability of other fungi 
species. In contrast, classrooms with a higher fungal diversity and lower concentrations of 
Penicillium spp were shown to be negatively associated with the prevalence of allergic 
sensitization, supporting the results from previous studies (Dannemiller et al., 2014, 
Behbod et al., 2015). Despite having a clear impact on sensitization, fungal diversity was 
not a risk factor for allergic rhinitis and atopic dermatitis, suggesting that exposure to 
microbiological agents may differently influence allergic diseases.  
Nevertheless, increased fungal diversity showed a tendency to be associated with a 
higher risk for lung function diagnosed asthma, but not for the other definitions. Children 
with lung function diagnosed asthma are generally in an uncontrolled or severe state of the 
disease. Therefore, a possible interpretation for these results may be hypothesized through 
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the fact that these children may already had a compromised immunomodulation and poor 
tolerance to fungal allergens, leading to an exacerbate state (with lung function alterations) 
of asthma when exposed to these environmental triggers. On the other hand, sensitization 
odds ratio was lower than the unity for all terciles and a significant tendency for a lower 
risk of allergic sensitization was observed in classrooms with higher fungal diversity, 
suggesting that exposure to environmental fungi has a completely different impact in 
asthma and allergy. Interestingly, when having all these results in mind, microbial diversity 
appears to be an environmental determinant primarily for allergic sensitization (either by 
promoting immunomodulation and prevention, or by leading to exacerbations when 
immune tolerance fails) and may only indirectly influence asthma prevalence through 
development of the allergic disease. Part of these results are in line with recent advances in 
the biodiversity and microbiome hypothesis (Fujimura and Lynch, 2015), supporting the 
importance of exposure to a diverse biome to prevent development of allergic sensitization 
and eventual development of allergic asthma in the paediatric population. Moreover, the 
results supporting the influence of classrooms’ microbiota biodiversity on early 
immunomodulation are interestingly similar to the those found by Ruokolainen et al. 
(2015) in green areas around cities. On the other hand, the results failed to support the 
evidence of beneficial exposure to bacterial endotoxins as observed in other studies 
concerning the biodiversity hypothesis (Carlsten et al., 2011). However, these are not 
isolated results. For instance, a domestic endotoxin exposure study in Cyprus also found 
higher exposure to endotoxins to be associated with increased allergic sensitization 
(Nicolaou et al., 2006). It is possible that regional environmental and genotypic differences 
(for instance, Mediterranean versus Nordic regions) may have a role in this controversy. 
More region-wide studies are needed to further clarify the biodiversity hypothesis.     
In conclusion, the exposure to microbial diversity in classrooms does not directly 
influence asthma prevalence in children, but appears to be a strong environmental 
determinant of allergic sensitization in the paediatric population, mediating 
immunomodulation and tolerance, which when not properly conducted, may result in 
development of the allergic disease, eventually leading to exacerbations in children with 
asthma. In face of these evidences, understanding the factors that influence microbial 
diversity in the school environment may lead to public health recommendations for 
reducing the development of allergic sensitization or prevent symptomatic exacerbations of 
asthma in the future. 
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6.2.2 Swimming pool exposure and increased airway reactivity to a beta-2 
agonist (study II) 
In this study, swimming pool attendance was associated with autonomic changes and 
airway alterations even in non-elite swimmers. Firstly, pupillometry showed that 
swimming pool exposure in school-aged children is associated with parasympathetic 
dysautonomia. Secondly, a higher volume of airway reversibility in response to an inhaled 
beta-2 agonist, suggestive of increased baseline airway smooth muscle constriction, was 
also observed in children that frequently attend swimming pools. Thirdly, these subtle 
changes appear to be reversible with swimming practice cessation, as no evidence of 
parasympathetic perturbances or airway constriction were found in children that used to 
swim in the past, even if they kept practicing any other type of sport. 
Neurogenic inflammation has been suggested to contribute to the recognized higher 
prevalence of asthma in athletes training and competing in environments with a high 
airway irritation potential (Silva and Moreira, 2015). Transient receptor potential vanilloid 
1 (TRPV1) is the centre of almost all neuronal inflammatory signalling pathways; this ion 
channel is often co-localized with sensory neuropeptides in the same axon of a primary 
neuron and its stimulation can lead to the release of these substances. It is expressed in 
primary sensory neurons, pulmonary smooth muscle cells, bronchial and tracheal epithelial 
cells and dendritic cells in the lung (Colsoul et al., 2009). Known physical activators of 
these channels include noxious temperature such as heat or cold, changes in membrane 
potential, mechanical or osmotic stress, and arachidonic acid metabolites (Banner et al., 
2011). A recent study showed increased levels of substance P in sputum of competitive 
swimmers suggesting it may be the result of a compensatory response to the sympathetic 
stimulation promoted by intensive training, neurogenic inflammatory response to swim 
stress and/or a local airway chemosensory reflex to chlorine by-products exposure in 
swimmers (Ramalho et al., 2014). However, altered parasympathetic tonus in healthy 
swimmers has until this moment been almost exclusively associated with endurance 
training. Although the high training volumes may certainly influence the autonomic 
nervous function, this study results now show that parasympathetic dysfunction does occur 
in healthy children swimmers not undergoing endurance training. Our findings further 
extend this observation suggesting that autonomic changes may not only be caused by high 
training volumes, but also by environmental exposure, even in young children. The 
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significantly higher exhaled NO levels observed in swimmers, although subtle and within 
physiologic reference values, support the co-existence of airways inflammation in those 
children. Therefore, it is possible that swimming pool exposure may be responsible for 
airway constriction at two levels: directly, by inhalation of disinfection by-products which 
will damage airway epithelium and increase oxidative stress (Bernard et al., 2015); and 
indirectly, by causing parasympathetic dysautonomia which may lead to a reflex 
vasoconstriction of bronchial venules, reducing the size of the bronchial lumen and 
generating increased airways resistance (Giacco et al., 2015). 
In the present study, the subtle changes associated with swimming pool attendance 
tended to disappear in children who discontinued swimming practice, since autonomic 
parameters, lung function and exhaled NO levels were not significantly different between 
past and non-swimmers. These results, coupled to the absence of significant correlations 
between the number of years in swimming practice and the airway reversibility or exhaled 
NO, suggests that swimming pool environment was the main responsible for the changes in 
airway inflammation biomarkers, which tend to disappear after ceasing the practice. In 
addition, parasympathetic activity also appears to be re-established after swimming 
cessation, since only sympathetic parameters seem to be significantly correlated with the 
number of years in swimming practice. Although this changes in sympathetic activity may 
be associated with more years of regular physical exercise (Sarmento et al., 2017), this 
cannot be concluded in the present study since only swimming practice was considered and 
children may have performed other physical activities at the same time period. 
Interestingly, these “reversibility” results support the hypothesis presented by Lomax 
(2016) regarding airway dysfunction in elite swimmers (Lomax, 2016). By systematically 
reviewing relevant publications, Lomax hypothesised that chlorine exposure in swimming 
pools coupled to endurance swimming exercises caused epithelial damage that could lead 
to several airway symptoms, including bronchoconstriction (Anderson and Kippelen, 
2005), but airway epithelium was estimated to be replenished every 30 to 50 days in the 
absence of continued damage (Williams, 2012, Lomax, 2016). When under continuous 
exposure, the injury-repair process of the airways epithelium may lead to respiratory 
disorders and, eventually, airway hyperresponsiveness (Anderson and Kippelen, 2005, 
Bougault et al., 2009, Lomax, 2016). While children in the present study were certainly not 
submitted to endurance training, they were still exposed to chlorine-based disinfection by-
products. 
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It is important to notice the several positive traits associated with swimming pool 
attendance. In line with other population-based studies (Goodman and Hays, 2008, Font-
Ribera et al., 2009, Font-Ribera et al., 2011, Jacobs et al., 2012, Font-Ribera et al., 2014), 
the results showed that swimming pool attendance was not associated with increased of 
allergic sensitization in children, although a trend for a higher risk of asthma (functional 
criteria), atopic eczema and rhinitis, was observed in swimmers. Swimming practice was 
also not associated with a higher prevalence of allergic sensitization and no adverse effects 
on baseline lung function parameters were observed. In fact, this study shows that children 
with more years in swimming practice generally have improved baseline lung function, 
supporting several other studies in the last two decades (Doherty and Dimitriou, 1997, 
Lazovic-Popovic et al., 2016), including those focused in prepubertal children, such as the 
one published by Courteix et al in 1997 (Courteix et al., 1997). However, seldom has 
exercise-induced bronchoconstriction been scrutinized in these studies and, as observable 
in the present study, children that attend swimming pools have a significantly higher 
exhaled NO and reversibility of FEV1. These results, coupled to the altered 
parasympathetic function in the current swimmers group suggests that exposure during 
indoor swimming may contribute to airways constriction independently of the training 
volume and asthma status. 
Two important aspects of the present study need to be taken into consideration: first, 
the airway reversibility and eosinophilic airway inflammation observed in active swimmers 
group are non-pathological according to current guidelines (Dweik et al., 2011, Global 
Initiative for Asthma, 2017); and second, the measured parameters appear to normalize 
after the practice cessation, as observed with the children in the PS group, independently of 
continuing other sportive activities. While the physiological mechanisms of the association 
between altered autonomic function and environmental exposure have not been fully 
explained, there is evidence showing that traffic-related air pollution may be responsible 
for disturbances of the autonomic system (Schwartz et al., 2005). Baja et al. (2013), using 
structural equation models, also observed that traffic pollution may decrease 
parasympathetic tone among diabetic elderly (Baja et al., 2013). Therefore, we may 
assume the observed autonomic changes could be associated with indoor swimming pool 
attendance in susceptible individuals, such as schoolchildren. 
Overall, while microbial exposure was only shown to indirectly influence asthma 
onset or exacerbations through allergic sensitization, swimming pool attendance appears to 
directly influence subtle changes associated with asthma like symptoms (including airway 
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smooth muscle constriction) in school-aged children. Although these changes are yet to 
reach pathological levels, they somehow resemble the large-scale changes associated with 
exercise-induced asthma in adults. Hence, exposure to swimming pool disinfectants should 
be considered as an environmental determinant for paediatric asthma.   
 
6.3 Exhaled VOC analysis in asthma diagnosis 
6.3.1 Accuracy of exhaled VOC biomarkers in asthma diagnosis (study III) 
The systematic review and meta-analysis showed that: firstly, exhaled VOC profiles 
have high sensitivity and specificity values for asthma diagnosis; secondly, individuals 
with asthma had 6 times higher chance of being diagnosed through exhaled VOC profiles 
than healthy controls; and thirdly, diagnosis odds ratios and AUC values were respectively 
49.3 and 0.94. Taken together, these observations suggest that exhaled VOC profile 
analysis may be an accurate test for asthma diagnosis. Nevertheless, these results should be 
interpreted with caution since the sensitivity and specificity values were retrieved from 
studies using not only different analysis methods but also different algorithms for VOC 
profiling. Therefore, despite how much promising the meta-analysis results may seem to 
be, there is still much to be done before introducing VOC biomarkers in a real clinical 
context. 
These findings are particularly important when compared with the sensitivity and 
specificity values of the currently used clinical tools in asthma diagnosis. For instance, the 
pooled sensitivity values of VOC profiles (87%) were higher than those obtained by 
spirometry considering both FEV1<80% and <90% (29% and 35%, respectively) (Smith et 
al., 2004, Schneider et al., 2009). Bronchodilator reversibility >12% also showed a poor 
sensitivity value (36%) when compared with VOC profiles (Tse et al., 2013). On the other 
hand, the GINA self-reported symptom questionnaires showed highly skewed 
sensitivity/specificity ratios (10.9 for ≥1 reported symptoms and 0.2 for ≥5 reported 
symptoms) while VOC profiles presented a ratio approximated to 1.0 (Lim et al., 2014).  
The systematic review also revealed that exhaled VOC analysis may be used for 
differentiating diseases that share symptoms with asthma, and since comorbidity is 
frequent in children, this is an attractive trait for paediatric asthma diagnosis. However, 
most of the reviewed studies were focused on comorbidities associated with elderly 
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subjects. Such is the case of COPD, which is often misdiagnosed as asthma in older 
individuals, particularly those who were significantly exposed to tobacco earlier in life. In 
a study conducted in the Netherlands, by Fens and co-workers (2009), the authors aimed to 
correctly distinguish a population comprised by 30 subjects with COPD, 20 subjects with 
asthma and 40 healthy controls, analysing their exhaled breath by eNose. The results 
showed that the breath-prints of individuals with asthma were significantly different from 
those with COPD or with no respiratory diseases (controls) with an accuracy of 
respectively 96 and 95%. The external validation of the mentioned results was 
demonstrated in a later study by Fens et al. (2011) were they showed that the accuracy for 
discriminating asthma from COPD was not confounded by “current smoking” status. 
However, these results were based on training sets, which required the reference standard 
to be known previously to the index test, thus being susceptible to diagnostic reporting bias 
according to STARD (Bossuyt et al., 2015). In addition, different results were obtained by 
Schivo et al. (2013), who after analysing exhaled VOC profiles through GC-DMS, 
observed that it was not possible to distinguish between COPD and asthma. Nevertheless, 
the small size of the sampled population (13 individuals with asthma and 5 with COPD) 
was pointed by the authors as the main reason behind these results.  
Contrasting with COPD, gastro-oesophageal reﬂux disease symptoms are not 
uncommon in children (Dent et al., 2005). Timms and co-workers (2012) performed a 
study aiming to distinguish patients suffering from common obstructive lung diseases 
(including asthma) with concomitant gastro-oesophageal reﬂux disease from those without 
gastro-oesophageal reﬂux disease, using eNose technology. The population included 20 
individuals with asthma and the results showed that the breath-prints from individuals with 
gastro-oesophageal reﬂux disease were highly distinguishable from those without reflux, in 
the asthma population. 
Unfortunately, there was limited research data concerning exhaled VOCs analysis to 
distinguish different phenotypes of asthma, which would enhance the potential of the 
method to assist the physician in properly prescribing corticosteroid treatment for 
paediatric asthma. Nevertheless, several studies showed that is possible to differentiate 
asthma severity using exhaled VOCs assessment (Olopade et al., 1997, Paredi et al., 2000, 
Delfino et al., 2003, Robroeks et al., 2013). This has also been shown using eNose 
technology, as demonstrated by the promising results from the study performed by van der 
Schee et al. (2013), where exhaled VOC profiles were able to predict steroid 
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responsiveness in patients with asthma with greater accuracy than exhaled NO and sputum 
eosinophils count.  
Concluding, the systematic review showed that exhaled VOC analysis may be used 
for both asthma diagnosis and severity monitoring. There is, however, a need for more 
studies contemplating proper internal and external validation procedures. In addition, 
further research on exhaled VOCs released from EBC samples needs to be conducted, 
preferably undergoing standardisable proceedings to allow reliable comparisons between 
studies. 
 
6.3.2 Electronic nose analysis of VOCs in EBC is able to identify children 
with asthma and those under corticosteroid therapy (study IV) 
The developed hierarchical model based on eNose VOC analysis of EBC samples was 
able to distinguish individuals with a medical diagnosis of paediatric asthma. In addition, 
persistent asthma patients that were under the need of inhaled corticosteroid therapy were 
significantly discernible with high accuracy, sensitivity and AUC values. These results 
considerably surpassed those from spirometry with bronchodilation challenge in asthma 
diagnosis. Therefore, exhaled VOC analysis, even when conducted through EBC samples, 
may be used as a handy complementary diagnostic methodology to assist the physician’s 
decision in administering corticosteroid therapy for paediatric patients with asthma. 
To our knowledge, this is the first study showing a methodology cable of 
distinguishing individuals with asthma through eNose EBC analysis. Overall, it is shown 
that breathprints in EBC provide similar AUC values to those shown in other studies using 
gas-phased exhaled breath and/or gas-chromatography methodologies for asthma diagnosis 
(Dallinga et al., 2010, Montuschi et al., 2010, Ibrahim et al., 2011, Caldeira et al., 2012, 
van der Schee et al., 2013, Smolinska et al., 2014). In fact, the measured VOC profiles 
allowed the inclusion of 93.1% individuals with persistent asthma and all of those with 
positive bronchodilation challenge in the same cluster of the developed model. Still, 
considering the high specificity of spirometry, both techniques could be used in 
combination to achieve a significantly reliable asthma diagnosis.    
The fact that individuals with persistent asthma were significantly distinguishable 
from those with intermittent asthma may be associated with the different degree of airway 
inflammation at sample collection. This is supported by the odds ratio results, which 
showed a significant tendency for medical asthma diagnosis and persistent asthma to be 
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included in the same cluster. As expected, individuals without asthma were significantly 
associated with the opposite cluster of the model, thus providing a clear opposing tendency 
for asthma diagnosis between clusters.  
The inflammatory process results in the excretion of specific metabolites through 
exhaled air, providing different volatile biomarkers in the condensate samples (Kharitonov 
and Barnes, 2001). These specific VOCs cannot be identified by eNose, as a more 
metabolomics-specialized method is required, such as GC-MS (Van Berkel et al., 2008, 
Ibrahim et al., 2011, Caldeira et al., 2012, Couto et al., 2017). However, the GC-MS 
methodology takes a substantial amount of time to analyse a sample, when compared to the 
10 second eNose sampling time, and requires a properly equipped laboratory meeting 
safety conditions to hold gas tanks. Moreover, instrumentation and analysis costs are 
considerably higher. Altogether, it would be difficult to apply GC-MS analysis in clinical 
settings when compared to a portable and relatively independent eNose system. 
Interestingly, participants with intermittent asthma were successfully discernible in the 
model, which again supports the discriminant potential of inflammation-originated VOCs. 
Although individuals with persistent asthma were included in the same group at the present 
study, Dragonieri et al. (2007) showed the breathprints of individuals with mild asthma are 
also discernible from those with severe asthma, even though a cross-validation value of 
only 65% was reported (Dragonieri et al., 2007). Therefore, although more studies with 
larger populations are needed, it is possible that exhaled VOC analysis may be able to 
further classify asthma severity according to airway inflammation degree. These results 
suggest that eNose exhaled VOC analysis would be particularly useful to identify 
individuals in need of corticosteroid therapy, thus assisting physician’s in reducing 
mistreatment or overtreatment of asthma in the paediatric population (Chung, 2016).   
Although the developed hierarchical model was already blindly built to the diagnostic 
standard results, an external validation of the model, tested on a new sample of individuals, 
should be performed to complete the STARD recommendations and to start implementing 
eNose VOC analysis on EBC samples for rapid and complementary asthma diagnosis in 
clinical settings. 
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6.4 Implications for practice and future research 
The results presented on this thesis support the need to further study environmental 
determinants of paediatric asthma in order to improve disease prevention. Although 
classroom and swimming pool exposure in children has been shown to influence (either 
directly or indirectly) asthma development or exacerbation, fully understanding the 
mechanisms behind the onset trigger would help to identify important prospects for 
eventual preventive therapeutics and behaviours. Moreover, epigenetics may be 
influencing the impact of environmental determinants, and it needs to be taken into account 
in future studies. In fact, this is already being performed by the Health and Environment-
wide Associations based on Large population Surveys (HEALS) project, using a cohort of 
tweens to comprehend the impact of epigenetics on environmental exposure susceptibility 
in children.  
In relation to exhaled VOC analysis, this thesis showed interesting results provided by 
an innovative methodology capable of accurately diagnosing paediatric asthma and 
distinguishing individuals under inhaled corticosteroid treatment. The sample collection 
and laboratory methodology presented in this work were designed while having in mind a 
possible implementation on a large-scaled clinical setting. Nevertheless, standardization 
procedures and external validation of the developed hierarchical model still need to be 
performed in order to successfully implement exhaled VOC analysis through eNose in a 
real clinical context. 
Overall, the present thesis is expected to contribute to the prevention and treatment of 
paediatric asthma, hopefully reducing its astonishing prevalence, morbidity and severity in 
a near future.      
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7 Conclusions 
In the present thesis, the highly prevalent paediatric asthma has been studied in terms 
of immunomodulatory environmental determinants and in means for correctly diagnosing 
(and consequently treating) this challenging disease. Based on the results obtained 
throughout the performed studies, the following conclusions were drawn: 
 
1. The exposure to microbial diversity in classrooms does not directly influence 
asthma prevalence in children, but may influence allergic sensitization in the 
paediatric population by mediating immunomodulation and allergen tolerance. 
Consequently, when this tolerance is not properly achieved, allergic disease may 
further develop with microbial exposure, eventually leading to exacerbations in 
children with asthma. 
 
2. Swimming pool attendance is associated with autonomic changes even in non-elite 
swimmers, such as children. Continued swimming pool exposure in school-aged 
children may cause parasympathetic dysautonomia and increased response to 
inhaled beta-2 agonists, consequently resulting in increased baseline airway smooth 
muscle constriction. These subtle changes appear to be reversible with swimming 
practice cessation. 
 
3. Exhaled VOCs have high sensitivity, specificity and AUC values for asthma 
diagnosis, and may assist the physician in determining the appropriate treatment for 
paediatric-aged individuals. However, there are still various constraints associated 
with standardization and validation of the collection and analysis procedures. 
 
4. Electronic nose analysis of EBC is able to distinguish individuals with asthma from 
those without asthma, and to identify individuals in need of corticosteroid therapy, 
even in a paediatric population, showing higher overall accuracy, sensitivity and 
AUC values when compared to spirometry with bronchodilation challenge. 
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Attachment I 
Attachment I - Quality of the systematically reviewed studies (study III). 
Study QUADAS items 
  1 2 3 4 5 6 7 8 9 10 11 12 13 14 Quality Score 
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Paredi et al. [32] No Yes Yes Yes Yes Yes Yes Yes Unclear Unclear Unclear Yes Yes Unclear 9 
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